Priothera Limited 07/09/2024 Approve Dec 31 2022 financial statements CORPORATE GOVERNANCE ISSUER 194134.000000 0.000000 FOR 194134.000000 FOR Priothera Limited 07/09/2024 Re-appoint statutory auditors AUDIT-RELATED ISSUER 194134.000000 0.000000 FOR 194134.000000 FOR Priothera Limited 07/09/2024 Authorize directors to approve remuneration of the statutory auditors for the calendar year 2023 AUDIT-RELATED ISSUER 194134.000000 0.000000 FOR 194134.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Richard H. Carmona, M.D. DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Dominic J. Caruso DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: W. Roy Dunbar DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Deborah Dunsire, M.D. DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: James H. Hinton DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Donald R. Knauss DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Bradley E. Lerman DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Maria N. Martinez DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Kevin M. Ozan DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Brian S. Tyler DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Election of eleven directors for a one-year term: Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Ratification of Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2025 AUDIT-RELATED ISSUER 10801.000000 0 AGAINST 10801.000000 AGAINST McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Advisory vote on Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 10801.000000 0 AGAINST 10801.000000 AGAINST McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Approve Amendment to Certificate of Incorporation to Provide for Officer Exculpation CORPORATE GOVERNANCE ISSUER 10801.000000 0 FOR 10801.000000 FOR McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Shareholder Proposal on Independent Board Chairman CORPORATE GOVERNANCE SECURITY HOLDER 10801.000000 0 FOR 10801.000000 AGAINST McKesson Corporation 58155Q103 US58155Q1031 07/31/2024 Shareholder Proposal on Report on Risks of State Policies Restricting Reproductive Health Care OTHER SOCIAL ISSUES SECURITY HOLDER 10801.000000 0 AGAINST 10801.000000 FOR Galera Therapeutics, Inc. 36338D108 US36338D1081 10/17/2024 To approve the liquidation and dissolution of the Company and the Plan of Liquidation and Dissolution (the "Plan of Dissolution") which, if approved, will authorize the Company's Board of Directors to liquidate and dissolve the Company in accordance with the Plan of Dissolution (the "Dissolution Proposal"). EXTRAORDINARY TRANSACTIONS ISSUER 161709.000000 0 FOR 161709.000000 FOR Galera Therapeutics, Inc. 36338D108 US36338D1081 10/17/2024 To adjourn the Special Meeting, from time to time, to a later date or dates, even if a quorum is present, to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting to approve the Dissolution Proposal. CORPORATE GOVERNANCE ISSUER 161709.000000 0 FOR 161709.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Craig Arnold DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Scott C. Donnelly DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Lidia L. Fonseca DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Andrea J. Goldsmith, Ph.D. DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Randall J. Hogan, III DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Gregory P. Lewis DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Kevin E. Lofton DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Geoffrey S. Martha DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Elizabeth G. Nabel, M.D. DIRECTOR ELECTIONS ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Electing, by separate resolutions, the ten director nominees named in the proxy statement to hold office until the 2025 Annual General Meeting of Medtronic plc (the "Company"): Kendall J. Powell DIRECTOR ELECTIONS ISSUER 84082.000000 0 AGAINST 84082.000000 AGAINST Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2025 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration; AUDIT-RELATED ISSUER 84082.000000 0 AGAINST 84082.000000 AGAINST Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Approving, on an advisory basis, the Company's executive compensation; SECTION 14A SAY-ON-PAY VOTES ISSUER 84082.000000 0 AGAINST 84082.000000 AGAINST Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Renewing the Board of Directors' authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 84082.000000 0 FOR 84082.000000 FOR Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and CAPITAL STRUCTURE ISSUER 84082.000000 0 AGAINST 84082.000000 AGAINST Medtronic Plc G5960L103 IE00BTN1Y115 10/17/2024 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. CAPITAL STRUCTURE ISSUER 84082.000000 0 FOR 84082.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Elect Brian McNamee as Director DIRECTOR ELECTIONS ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Elect Andrew Cuthbertson as Director DIRECTOR ELECTIONS ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Elect Alison Watkins as Director DIRECTOR ELECTIONS ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Elect Samantha Lewis as Director DIRECTOR ELECTIONS ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Elect Elaine Sorg as Director DIRECTOR ELECTIONS ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Approve Remuneration Report COMPENSATION ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Approve Grant of Performance Share Units to Paul McKenzie COMPENSATION ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Approve Re-insertion of Proportional Takeover Approval Provisions in Constitution SHAREHOLDER RIGHTS AND DEFENSES ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Approve Potential Leaving Entitlements for Directors of CSL Subsidiary Entities, Excluding KMP and GLG Members COMPENSATION ISSUER 30845.000000 0 FOR 30845.000000 FOR CSL Limited Q3018U109 AU000000CSL8 10/29/2024 Approve Increase to Non-Executive Director Fee Cap COMPENSATION ISSUER 30845.000000 0 FOR 30845.000000 NONE ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Carol Burt DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Christopher DelOrefice DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Jan De Witte DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Karen Drexler DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Michael Farrell DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Peter Farrell DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Harjit Gill DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: John Hernandez DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Richard Sulpizio DIRECTOR ELECTIONS ISSUER 15396.000000 0 AGAINST 15396.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Desney Tan DIRECTOR ELECTIONS ISSUER 15396.000000 0 FOR 15396.000000 FOR ResMed Inc. 761152107 US7611521078 11/20/2024 Elect 11 directors, each to serve until our 2025 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2024 annual meeting are: Ronald Taylor DIRECTOR ELECTIONS ISSUER 15396.000000 0 AGAINST 15396.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/20/2024 Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2025. AUDIT-RELATED ISSUER 15396.000000 0 AGAINST 15396.000000 AGAINST ResMed Inc. 761152107 US7611521078 11/20/2024 Approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 15396.000000 0 AGAINST 15396.000000 AGAINST State Street Institutional Investment Trust 857492706 US8574927062 12/06/2024 To Elect a Board of Trustees: Patrick J. Riley DIRECTOR ELECTIONS ISSUER 27390820.470000 0 FOR 27390820.470000 FOR State Street Institutional Investment Trust 857492706 US8574927062 12/06/2024 To Elect a Board of Trustees: Donna M. Rapaccioli DIRECTOR ELECTIONS ISSUER 27390820.470000 0 FOR 27390820.470000 FOR State Street Institutional Investment Trust 857492706 US8574927062 12/06/2024 To Elect a Board of Trustees: Margaret K. McLaughlin DIRECTOR ELECTIONS ISSUER 27390820.470000 0 FOR 27390820.470000 FOR State Street Institutional Investment Trust 857492706 US8574927062 12/06/2024 To Elect a Board of Trustees: George M. Pereira DIRECTOR ELECTIONS ISSUER 27390820.470000 0 FOR 27390820.470000 FOR State Street Institutional Investment Trust 857492706 US8574927062 12/06/2024 To Elect a Board of Trustees: Mark E. Swanson DIRECTOR ELECTIONS ISSUER 27390820.470000 0 FOR 27390820.470000 FOR State Street Institutional Investment Trust 857492706 US8574927062 12/06/2024 To Elect a Board of Trustees: Jeanne LaPorta DIRECTOR ELECTIONS ISSUER 27390820.470000 0 FOR 27390820.470000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: William M. Brown DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Catherine M. Burzik DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Carrie Byington DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: R. Andrew Eckert DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Claire M. Fraser DIRECTOR ELECTIONS ISSUER 36420.000000 0 AGAINST 36420.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Jeffrey W. Henderson DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Christopher Jones DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Thomas E. Polen DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Timothy M. Ring DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Bertram L. Scott DIRECTOR ELECTIONS ISSUER 36420.000000 0 AGAINST 36420.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Election of Directors: Joanne Waldstreicher DIRECTOR ELECTIONS ISSUER 36420.000000 0 FOR 36420.000000 FOR Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Ratification of the selection of the independent registered public accounting firm. AUDIT-RELATED ISSUER 36420.000000 0 AGAINST 36420.000000 AGAINST Becton, Dickinson and Company 075887109 US0758871091 01/28/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 36420.000000 0 AGAINST 36420.000000 AGAINST Galera Therapeutics, Inc. 36338D108 US36338D1081 02/24/2025 Election of Class II Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Lawrence Alleva DIRECTOR ELECTIONS ISSUER 161709.000000 0 WITHHOLD 161709.000000 AGAINST Galera Therapeutics, Inc. 36338D108 US36338D1081 02/24/2025 Election of Class II Directors to serve until the 2027 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Kevin Lokay DIRECTOR ELECTIONS ISSUER 161709.000000 0 WITHHOLD 161709.000000 AGAINST Galera Therapeutics, Inc. 36338D108 US36338D1081 02/24/2025 To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. AUDIT-RELATED ISSUER 161709.000000 0 FOR 161709.000000 FOR Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Otsuka, Ichiro DIRECTOR ELECTIONS ISSUER 20808.000000 0 FOR 20808.000000 FOR Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Inoue, Makoto DIRECTOR ELECTIONS ISSUER 20808.000000 0 FOR 20808.000000 FOR Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Matsuo, Yoshiro DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Makino, Yuko DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Takagi, Shuichi DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Kobayashi, Masayuki DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Tojo, Noriko DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Higuchi, Tatsuo DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Matsutani, Yukio DIRECTOR ELECTIONS ISSUER 20808.000000 0 FOR 20808.000000 FOR Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Aoki, Yoshihisa DIRECTOR ELECTIONS ISSUER 20808.000000 0 ABSTAIN 20808.000000 AGAINST Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Mita, Mayo DIRECTOR ELECTIONS ISSUER 20808.000000 0 FOR 20808.000000 FOR Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Kitachi, Tatsuaki DIRECTOR ELECTIONS ISSUER 20808.000000 0 FOR 20808.000000 FOR Otsuka Holdings Co., Ltd. J63117105 JP3188220002 03/28/2025 Elect Director Seguchi, Jiro DIRECTOR ELECTIONS ISSUER 20808.000000 0 FOR 20808.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Approve Dividends CAPITAL STRUCTURE ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Reappoint PricewaterhouseCoopers LLP as Auditors AUDIT-RELATED ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise Board to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Michel Demare as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Pascal Soriot as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Aradhana Sarin as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Philip Broadley as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Euan Ashley as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Elect Birgit Conix as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Elect Rene Haas as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Elect Karen Knudsen as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Diana Layfield as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Anna Manz as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Sheri McCoy as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Tony Mok as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Nazneen Rahman as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Re-elect Marcus Wallenberg as Director DIRECTOR ELECTIONS ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Approve Remuneration Report COMPENSATION ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise UK Political Donations and Expenditure OTHER SOCIAL ISSUES ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 339819.000000 0 FOR 339819.000000 FOR AstraZeneca PLC 046353108 US0463531089 04/11/2025 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 339819.000000 0 FOR 339819.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Raquel C. Bono, M.D. DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 7418.000000 0 AGAINST 7418.000000 AGAINST Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: David T. Feinberg, M.D. DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Wayne A. I. Frederick, M.D. DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: John W. Garratt DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Kurt J. Hilzinger DIRECTOR ELECTIONS ISSUER 7418.000000 0 AGAINST 7418.000000 AGAINST Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Karen W. Katz DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Marcy S. Klevorn DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Jorge S. Mesquita DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: James A. Rechtin DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 Election of Directors: Gordon Smith DIRECTOR ELECTIONS ISSUER 7418.000000 0 FOR 7418.000000 FOR Humana Inc. 444859102 US4448591028 04/17/2025 The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. AUDIT-RELATED ISSUER 7418.000000 0 AGAINST 7418.000000 AGAINST Humana Inc. 444859102 US4448591028 04/17/2025 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 7418.000000 0 AGAINST 7418.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Thomas F. Frist III DIRECTOR ELECTIONS ISSUER 14382.000000 0 AGAINST 14382.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Samuel N. Hazen DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Robert J. Dennis DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Nancy-Ann DeParle DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: William R. Frist DIRECTOR ELECTIONS ISSUER 14382.000000 0 AGAINST 14382.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Hugh F. Johnston DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Michael W. Michelson DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Wayne J. Riley M.D. DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Election of Directors: Andrea B. Smith DIRECTOR ELECTIONS ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 14382.000000 0 AGAINST 14382.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 14382.000000 0 AGAINST 14382.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 To approve the First Amendment to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates. COMPENSATION ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 To approve an amendment to our amended and restated certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law. CORPORATE GOVERNANCE ISSUER 14382.000000 0 FOR 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Stockholder proposal, if properly presented at the meeting, regarding lavish golden parachutes. COMPENSATION SECURITY HOLDER 14382.000000 0 FOR 14382.000000 AGAINST HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Stockholder proposal, if properly presented at the meeting, regarding an amendment to Patient Safety and Quality of Care Committee charter. OTHER SOCIAL ISSUES SECURITY HOLDER 14382.000000 0 AGAINST 14382.000000 FOR HCA Healthcare, Inc. 40412C101 US40412C1018 04/24/2025 Stockholder proposal, if properly presented at the meeting, regarding report on acquisition strategy. OTHER SOCIAL ISSUES SECURITY HOLDER 14382.000000 0 AGAINST 14382.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Scott M. Brinker DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Katherine M. Sandstrom DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: John T. Thomas DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Brian G. Cartwright DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: James B. Connor DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: R. Kent Griffin, Jr. DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Pamela J. Kessler DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Sara G. Lewis DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Ava E. Lias-Booker DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Tommy G. Thompson DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Election of Directors: Richard A. Weiss DIRECTOR ELECTIONS ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Approval of 2024 executive compensation on an advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Approval of the Healthpeak Properties, Inc. Employee Stock Purchase Plan. COMPENSATION ISSUER 279943.000000 0 FOR 279943.000000 FOR Healthpeak Properties, Inc. 42250P103 US42250P1030 04/24/2025 Ratification of the appointment of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 279943.000000 0 FOR 279943.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Ari Bousbib DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Carol J. Burt DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): John G. Danhakl DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): James A. Fasano DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Colleen A. Goggins DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): John M. Leonard, M.D. DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Leslie Wims Morris DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Todd B. Sisitsky DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 The election of each of the director nominees listed below (a through i): Sheila A. Stamps DIRECTOR ELECTIONS ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 Approve an advisory (non-binding) resolution to approve IQVIA'S executive compensation (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 10611.000000 0 AGAINST 10611.000000 AGAINST IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 10611.000000 0 AGAINST 10611.000000 AGAINST IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 Approve a Company proposal to amend IQVIA's Certificate of Incorporation regarding officer exculpation. CORPORATE GOVERNANCE ISSUER 10611.000000 0 FOR 10611.000000 FOR IQVIA Holdings Inc. 46266C105 US46266C1053 04/24/2025 If properly presented, a stockholder proposal concerning special stockholder meetings. CORPORATE GOVERNANCE SECURITY HOLDER 10611.000000 0 FOR 10611.000000 AGAINST Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Darius Adamczyk DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mary C. Beckerle DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Joaquin Duato DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Marillyn A. Hewson DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Paula A. Johnson DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Hubert Joly DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mark B. McClellan DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Mark A. Weinberger DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Nadja Y. West DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Election of Directors: Eugene A. Woods DIRECTOR ELECTIONS ISSUER 104796.000000 0 FOR 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 104796.000000 0 AGAINST 104796.000000 AGAINST Johnson & Johnson 478160104 US4781601046 04/24/2025 Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 104796.000000 0 AGAINST 104796.000000 AGAINST Johnson & Johnson 478160104 US4781601046 04/24/2025 Shareholder opportunity to vote on excessive golden parachutes COMPENSATION SECURITY HOLDER 104796.000000 0 AGAINST 104796.000000 FOR Johnson & Johnson 478160104 US4781601046 04/24/2025 Produce a human rights impact assessment HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 104796.000000 0 AGAINST 104796.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Ronald E. Blaylock DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Albert Bourla DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Mortimer J. Buckley DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Susan Desmond-Hellmann DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Joseph J. Echevarria DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Scott Gottlieb DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Susan Hockfield DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Dan R. Littman DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Shantanu Narayen DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Suzanne Nora Johnson DIRECTOR ELECTIONS ISSUER 207761.000000 0 AGAINST 207761.000000 AGAINST Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: James Quincey DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: James C. Smith DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Election of Directors: Cyrus Taraporevala DIRECTOR ELECTIONS ISSUER 207761.000000 0 FOR 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 207761.000000 0 AGAINST 207761.000000 AGAINST Pfizer Inc. 717081103 US7170811035 04/24/2025 2025 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 207761.000000 0 AGAINST 207761.000000 AGAINST Pfizer Inc. 717081103 US7170811035 04/24/2025 Shareholder Vote Regarding Golden Parachutes COMPENSATION SECURITY HOLDER 207761.000000 0 AGAINST 207761.000000 FOR Pfizer Inc. 717081103 US7170811035 04/24/2025 Issue a Report Evaluating the Risks Related to Religious Discrimination Against Employees ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 207761.000000 0 AGAINST 207761.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To re-elect Kenneth Cunningham, M.D. as a director of the Company. DIRECTOR ELECTIONS ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To re-elect Vikas Sinha as a director of the Company. DIRECTOR ELECTIONS ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To re-elect James Brady as a director of the Company. DIRECTOR ELECTIONS ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To receive and adopt the U.K. statutory annual accounts and Directors' report for the year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To receive and approve, as a non-binding advisory resolution, the U.K. statutory Directors' Remuneration Report for the year ended December 31, 2024. COMPENSATION ISSUER 2.000000 0 AGAINST 2.000000 AGAINST Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To re-appoint Ernst & Young LLP as the Company's auditors, to hold office until the conclusion of the next annual general meeting of shareholders. AUDIT-RELATED ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To authorize the Audit and Risk Committee to determine the auditors' remuneration for the year ending December 31, 2025. AUDIT-RELATED ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2.000000 0 AGAINST 2.000000 AGAINST Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To authorize the Board of Directors to exercise all the powers of the Company to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds7,031,895 (being up to a maximum of 140,637,892 shares representing 20% of the Company's existing ordinary share capital as at the close of business on March 11, 2025 (being the latest practicable date prior to publication of this document)). CAPITAL STRUCTURE ISSUER 2.000000 0 FOR 2.000000 FOR Verona Pharma Plc G9337X139 GB00BYW2KH80 04/24/2025 To authorize the Board of Directors to allot equity securities for cash and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561(1) of the Companies Act does not apply to any such allotment. CAPITAL STRUCTURE ISSUER 2.000000 0 AGAINST 2.000000 AGAINST Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: R. J. Alpern DIRECTOR ELECTIONS ISSUER 149266.000000 0 AGAINST 149266.000000 AGAINST Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: C. Babineaux-Fontenot DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: S. E. Blount DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: R. B. Ford DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: P. Gonzalez DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. A. Kumbier DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: D. W. McDew DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: N. McKinstry DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. G. O'Grady DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: M. F. Roman DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: D. J. Starks DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Election of 12 Directors: J. G. Stratton DIRECTOR ELECTIONS ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Ratification of Ernst & Young LLP As Auditors AUDIT-RELATED ISSUER 149266.000000 0 FOR 149266.000000 FOR Abbott Laboratories 002824100 US0028241000 04/25/2025 Say on Pay - An Advisory Vote on the Approval of Executive Compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 149266.000000 0 AGAINST 149266.000000 AGAINST Bayer AG D0712D163 DE000BAY0017 04/25/2025 Receive Financial Statements and Statutory Reports; Approve Allocation of Income and Dividends of EUR 0.11 per Share for Fiscal Year 2024 CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 173684.000000 0 FOR 173684.000000 FOR Bayer AG D0712D163 DE000BAY0017 04/25/2025 Approve Discharge of Management Board for Fiscal Year 2024 CORPORATE GOVERNANCE ISSUER 173684.000000 0 FOR 173684.000000 FOR Bayer AG D0712D163 DE000BAY0017 04/25/2025 Approve Discharge of Supervisory Board for Fiscal Year 2024 CORPORATE GOVERNANCE ISSUER 173684.000000 0 FOR 173684.000000 FOR Bayer AG D0712D163 DE000BAY0017 04/25/2025 Elect Alberto Weisser to the Supervisory Board DIRECTOR ELECTIONS ISSUER 173684.000000 0 FOR 173684.000000 FOR Bayer AG D0712D163 DE000BAY0017 04/25/2025 Approve Remuneration Report COMPENSATION ISSUER 173684.000000 0 AGAINST 173684.000000 AGAINST Bayer AG D0712D163 DE000BAY0017 04/25/2025 Approve Remuneration of Supervisory Board COMPENSATION ISSUER 173684.000000 0 FOR 173684.000000 FOR Bayer AG D0712D163 DE000BAY0017 04/25/2025 Approve Creation of EUR 875 Million Pool of Authorized Capital with Preemptive Rights CAPITAL STRUCTURE ISSUER 173684.000000 0 AGAINST 173684.000000 AGAINST Bayer AG D0712D163 DE000BAY0017 04/25/2025 Approve Virtual-Only Shareholder Meetings Until 2027 CORPORATE GOVERNANCE ISSUER 173684.000000 0 AGAINST 173684.000000 AGAINST Bayer AG D0712D163 DE000BAY0017 04/25/2025 Ratify Deloitte GmbH as Auditors for Fiscal Year 2025 and for the Review of Interim Financial Statements for Fiscal Year 2025 and First Quarter of Fiscal Year 2026 AUDIT-RELATED ISSUER 173684.000000 0 FOR 173684.000000 FOR Bayer AG D0712D163 DE000BAY0017 04/25/2025 Voting Instructions for Motions or Nominations by Shareholders that are not Made Accessible Before the AGM and that are Made or Amended in the Course of the AGM CORPORATE GOVERNANCE ISSUER 173684.000000 0 AGAINST 173684.000000 NONE Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Barbara L. Brasier DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Leo P. Grohowski DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Stephen H. Lockhart DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Steven J. Orlando DIRECTOR ELECTIONS ISSUER 6616.000000 0 AGAINST 6616.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Ronna E. Romney DIRECTOR ELECTIONS ISSUER 6616.000000 0 AGAINST 6616.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Richard M. Schapiro DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Dale B. Wolf DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Richard C. Zoretic DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To elect nine directors to hold office until the 2026 Annual Meeting: Joseph M. Zubretsky DIRECTOR ELECTIONS ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6616.000000 0 AGAINST 6616.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 6616.000000 0 AGAINST 6616.000000 AGAINST Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 To consider and approve the Company's 2025 Equity Incentive Plan. COMPENSATION ISSUER 6616.000000 0 FOR 6616.000000 FOR Molina Healthcare, Inc. 60855R100 US60855R1005 04/30/2025 Stockholder proposal regarding stockholders ability to call a special stockholders meeting, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 6616.000000 0 FOR 6616.000000 AGAINST Sanofi 80105N105 US80105N1054 04/30/2025 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Allocation of Income and Dividends of EUR 3.92 per Share CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Transaction with l'Oreal Re: Share Repurchase Agreement CORPORATE GOVERNANCE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Ratify Appointment of Jean-Paul Kress as Director DIRECTOR ELECTIONS ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Reelect Carole Ferrand as Director DIRECTOR ELECTIONS ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Reelect Barbara Lavernos as Director DIRECTOR ELECTIONS ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Reelect Emile Voest as Director DIRECTOR ELECTIONS ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Reelect Antoine Yver as Director DIRECTOR ELECTIONS ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Compensation of Frederic Oudea, Chairman of the Board SECTION 14A SAY-ON-PAY VOTES ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Compensation of Paul Hudson, CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 196048.000000 0 AGAINST 196048.000000 AGAINST Sanofi 80105N105 US80105N1054 04/30/2025 Approve Remuneration Policy of Directors COMPENSATION ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Remuneration Policy of CEO COMPENSATION ISSUER 196048.000000 0 AGAINST 196048.000000 AGAINST Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Decrease in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights (Rights Issue) up to Aggregate Nominal Amount of EUR 997 Million CAPITAL STRUCTURE ISSUER 196048.000000 0 AGAINST 196048.000000 AGAINST Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 240 Million CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 240 Million CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Approve Issuance of Debt Securities Giving Access to New Shares of Subsidiaries and/or Debt Securities, up to Aggregate Amount of EUR 7 Billion CAPITAL STRUCTURE OTHER Debt Related ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 18, 19, and 20 CAPITAL STRUCTURE ISSUER 196048.000000 0 AGAINST 196048.000000 AGAINST Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Capitalization of Reserves of Up to EUR 500 Million for Bonus Issue or Increase in Par Value CAPITAL STRUCTURE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries COMPENSATION ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Amend Articles 3 and 13 of Bylaws CORPORATE GOVERNANCE ISSUER 196048.000000 0 FOR 196048.000000 FOR Sanofi 80105N105 US80105N1054 04/30/2025 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 196048.000000 0 FOR 196048.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Approve Remuneration Report COMPENSATION ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Approve Final Dividend CAPITAL STRUCTURE ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Elect Sybella Stanley as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Rupert Soames as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Jo Hallas as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Simon Lowth as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect John Ma as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Jeremy Maiden as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Katarzyna Mazur-Hofsaess as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Deepak Nath as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Marc Owen as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Angie Risley as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect John Rogers as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Re-elect Bob White as Director DIRECTOR ELECTIONS ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Reappoint Deloitte LLP as Auditors AUDIT-RELATED ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Authorise Board to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 118710.000000 0 FOR 118710.000000 FOR Smith & Nephew plc 83175M205 US83175M2052 04/30/2025 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 118710.000000 0 FOR 118710.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Yoshiaki Fujimori DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: David C. Habiger DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Edward J. Ludwig DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Michael F. Mahoney DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Jessica L. Mega DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Susan E. Morano DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Cheryl Pegus DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: John E. Sununu DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: David S. Wichmann DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Proposal to elect ten Directors: Ellen M. Zane DIRECTOR ELECTIONS ISSUER 59806.000000 0 FOR 59806.000000 FOR Boston Scientific Corporation 101137107 US1011371077 05/01/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 59806.000000 0 AGAINST 59806.000000 AGAINST Boston Scientific Corporation 101137107 US1011371077 05/01/2025 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year. AUDIT-RELATED ISSUER 59806.000000 0 AGAINST 59806.000000 AGAINST Boston Scientific Corporation 101137107 US1011371077 05/01/2025 Stockholder proposal titled "Support Simple Majority Vote." CORPORATE GOVERNANCE SECURITY HOLDER 59806.000000 0 FOR 59806.000000 NONE Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 Election of Directors: Cathrine Cotman DIRECTOR ELECTIONS ISSUER 14900.000000 0 FOR 14900.000000 FOR Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 Election of Directors: David Dupuy DIRECTOR ELECTIONS ISSUER 14900.000000 0 FOR 14900.000000 FOR Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 Election of Directors: Alan Gardner DIRECTOR ELECTIONS ISSUER 14900.000000 0 FOR 14900.000000 FOR Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 Election of Directors: Claire Gulmi DIRECTOR ELECTIONS ISSUER 14900.000000 0 FOR 14900.000000 FOR Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 Election of Directors: Robert Hensley DIRECTOR ELECTIONS ISSUER 14900.000000 0 FOR 14900.000000 FOR Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 Election of Directors: Lawrence Van Horn DIRECTOR ELECTIONS ISSUER 14900.000000 0 FOR 14900.000000 FOR Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 To approve, on a non-binding advisory basis, the following resolutions: RESOLVED, that the stockholders of Community Healthcare Trust Incorporated approve, on a non-binding advisory basis, the compensation of the named executive officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2025 annual meeting of stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 14900.000000 0 AGAINST 14900.000000 AGAINST Community Healthcare Trust Incorporated 20369C106 US20369C1062 05/01/2025 To ratify the appointment of BDO USA, P.C. as the Company's independent registered public accountants for 2025. AUDIT-RELATED ISSUER 14900.000000 0 FOR 14900.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Craig H. Barratt, Ph.D. DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Joseph C. Beery DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Lewis Chew DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Gary S. Guthart, Ph.D. DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Amal M. Johnson DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Sreelakshmi Kolli DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Amy L. Ladd, M.D. DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Keith R. Leonard, Jr. DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Jami Dover Nachtsheim DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: Monica P. Reed, M.D. DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 Election of Directors: David J. Rosa DIRECTOR ELECTIONS ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22725.000000 0 AGAINST 22725.000000 AGAINST Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. COMPENSATION ISSUER 22725.000000 0 FOR 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The stockholder proposal purportedly "to improve the executive compensation program," if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 22725.000000 0 AGAINST 22725.000000 FOR Intuitive Surgical, Inc. 46120E602 US46120E6023 05/01/2025 The stockholder proposal that is titled "requesting a shareholder approval requirement for excessive golden parachutes," if properly presented at the Annual Meeting. COMPENSATION SECURITY HOLDER 22725.000000 0 FOR 22725.000000 AGAINST Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Bradley A. Alford DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Orlando D. Ashford DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Julia M. Brown DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Kevin Egan DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Adriana Karaboutis DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Jeffrey B. Kindler DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Patrick Lockwood-Taylor DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Albert A. Manzone DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Donal O'Connor DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Geoffrey M. Parker DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To elect, by separate resolutions, eleven director nominees to serve until the 2026 Annual General Meeting of Shareholders: Jonas Samuelson DIRECTOR ELECTIONS ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor; AUDIT-RELATED ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To provide advisory approval of the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 15882.000000 0 AGAINST 15882.000000 AGAINST Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To renew the Board's authority to issue shares under Irish law; CAPITAL STRUCTURE ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To renew the Board's authority to opt-out of statutory pre-emption rights under Irish law; CAPITAL STRUCTURE ISSUER 15882.000000 0 AGAINST 15882.000000 AGAINST Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To approve an increase in the maximum number of directors who may be appointed to the Board; CORPORATE GOVERNANCE ISSUER 15882.000000 0 FOR 15882.000000 FOR Perrigo Company plc G97822103 IE00BGH1M568 05/01/2025 To approve amendments to the Company's Articles of Association; CORPORATE GOVERNANCE ISSUER 15882.000000 0 FOR 15882.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Ralph Alvarez DIRECTOR ELECTIONS ISSUER 35804.000000 0 AGAINST 35804.000000 AGAINST Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Mary Lynne Hedley DIRECTOR ELECTIONS ISSUER 35804.000000 0 FOR 35804.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Kimberly Johnson DIRECTOR ELECTIONS ISSUER 35804.000000 0 FOR 35804.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/05/2025 Election of the following directors, each to serve a three-year term: Juan Luciano DIRECTOR ELECTIONS ISSUER 35804.000000 0 FOR 35804.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval, on an advisory basis, of the compensation paid to the company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 35804.000000 0 FOR 35804.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/05/2025 Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2025. AUDIT-RELATED ISSUER 35804.000000 0 AGAINST 35804.000000 AGAINST Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 35804.000000 0 FOR 35804.000000 FOR Eli Lilly and Company 532457108 US5324571083 05/05/2025 Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions. CORPORATE GOVERNANCE ISSUER 35804.000000 0 FOR 35804.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Peter J. Arduini DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Deepak L. Bhatt, M.D., M.P.H., M.B.A. DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Christopher S. Boerner, Ph.D. DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Julia A. Haller, M.D. DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Manuel Hidalgo Medina, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Michael R. McMullen DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Paula A. Price DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Derica W. Rice DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Theodore R. Samuels DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Karen H. Vousden, Ph.D. DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Election of Directors: Phyllis R. Yale DIRECTOR ELECTIONS ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES ISSUER 170347.000000 0 AGAINST 170347.000000 AGAINST Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Ratification of the Appointment of an Independent Registered Public Accounting Firm AUDIT-RELATED ISSUER 170347.000000 0 FOR 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Shareholder Proposal on Corporate Financial Sustainability ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 170347.000000 0 AGAINST 170347.000000 FOR Bristol-Myers Squibb Company 110122108 US1101221083 05/06/2025 Shareholder Proposal on a Request to Cease DEI Efforts ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 170347.000000 0 AGAINST 170347.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair DIRECTOR ELECTIONS ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan DIRECTOR ELECTIONS ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna DIRECTOR ELECTIONS ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH DIRECTOR ELECTIONS ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales DIRECTOR ELECTIONS ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales DIRECTOR ELECTIONS ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D. DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2026 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD DIRECTOR ELECTIONS ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Danaher Corporation 235851102 US2358511028 05/06/2025 To ratify the selection of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 33633.000000 0 FOR 33633.000000 FOR Danaher Corporation 235851102 US2358511028 05/06/2025 To approve on an advisory basis the Company's named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 33633.000000 0 AGAINST 33633.000000 AGAINST Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D. DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D. DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D. DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D. DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters DIRECTOR ELECTIONS ISSUER 37859.000000 0 FOR 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 37859.000000 0 AGAINST 37859.000000 AGAINST Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 37859.000000 0 AGAINST 37859.000000 AGAINST Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting the CEO pay ratio factor be included in the Company's executive compensation programs, if properly presented at the Annual Meeting. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 37859.000000 0 AGAINST 37859.000000 FOR Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. CORPORATE GOVERNANCE SECURITY HOLDER 37859.000000 0 FOR 37859.000000 AGAINST Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting a comprehensive human rights policy and human rights due diligence process, if properly presented at the Annual Meeting. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 37859.000000 0 FOR 37859.000000 AGAINST Gilead Sciences, Inc. 375558103 US3755581036 05/07/2025 To vote on a stockholder proposal requesting a report on the risks of the Company's DEI practices for contractors, if properly presented at the Annual Meeting. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 37859.000000 0 AGAINST 37859.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Election of Directors (Proposal One): Stuart M. Essig DIRECTOR ELECTIONS ISSUER 2547.000000 0 FOR 2547.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Election of Directors (Proposal One): Jonathan J. Mazelsky DIRECTOR ELECTIONS ISSUER 2547.000000 0 FOR 2547.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Election of Directors (Proposal One): M. Anne Szostak DIRECTOR ELECTIONS ISSUER 2547.000000 0 FOR 2547.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two). AUDIT-RELATED ISSUER 2547.000000 0 AGAINST 2547.000000 AGAINST IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). SECTION 14A SAY-ON-PAY VOTES ISSUER 2547.000000 0 AGAINST 2547.000000 AGAINST IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Amend Certificate of Incorporation to Remove Supermajority Voting Provisions (Proposal Four). CORPORATE GOVERNANCE ISSUER 2547.000000 0 FOR 2547.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Amend Certificate of Incorporation to Reflect New Delaware Law Provisions Allowing for Officer Exculpation (Proposal Five). CORPORATE GOVERNANCE ISSUER 2547.000000 0 FOR 2547.000000 FOR IDEXX Laboratories, Inc. 45168D104 US45168D1046 05/07/2025 Shareholder Proposal Regarding the Annual Election of Directors (Proposal Six). SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 2547.000000 0 FOR 2547.000000 NONE DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Kevin R. Sayer DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Steven R. Altman DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Nicholas Augustinos DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Richard A. Collins DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Rimma Driscoll DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Mark G. Foletta DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Renee Gala DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Bridgette P. Heller DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To elect ten nominees for director, each to hold office until our 2026 annual meeting of stockholders: Kyle Malady DIRECTOR ELECTIONS ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To ratify the selection by the Audit Committee of our Board of Directors of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024. SECTION 14A SAY-ON-PAY VOTES ISSUER 54689.000000 0 AGAINST 54689.000000 AGAINST DexCom, Inc. 252131107 US2521311074 05/08/2025 To approve our Amended and Restated 2015 Equity Incentive Plan (as amended and restated) to, among other things, increase the number of shares reserved for issuance thereunder by 3,400,000 shares. COMPENSATION ISSUER 54689.000000 0 FOR 54689.000000 FOR DexCom, Inc. 252131107 US2521311074 05/08/2025 To approve our Amended and Restated 2015 Employee Stock Purchase Plan to, among other things, increase the number of shares reserved for issuance thereunder by 8,000,000 shares. COMPENSATION ISSUER 54689.000000 0 FOR 54689.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Mary K. Brainerd DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Giovanni Caforio, M.D. DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Kevin A. Lobo DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Emmanuel P. Maceda DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Sherilyn S. McCoy DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Rachel M. Ruggeri DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Andrew K. Silvernail DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Lisa M. Skeete Tatum DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Ronda E. Stryker DIRECTOR ELECTIONS ISSUER 21256.000000 0 AGAINST 21256.000000 AGAINST Stryker Corporation 863667101 US8636671013 05/08/2025 Election of Ten Directors: Rajeev Suri DIRECTOR ELECTIONS ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2025. AUDIT-RELATED ISSUER 21256.000000 0 AGAINST 21256.000000 AGAINST Stryker Corporation 863667101 US8636671013 05/08/2025 Approval of the 2011 Long-Term Incentive Plan, as Amended and Restated. COMPENSATION ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Approval of the 2011 Performance Incentive Award Plan, as Amended and Restated. COMPENSATION ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Approval of the 2008 Stock Purchase Plan, as Amended and Restated. COMPENSATION ISSUER 21256.000000 0 FOR 21256.000000 FOR Stryker Corporation 863667101 US8636671013 05/08/2025 Advisory Vote to Approve Named Executive Officer Compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 21256.000000 0 AGAINST 21256.000000 AGAINST Stryker Corporation 863667101 US8636671013 05/08/2025 Shareholder Proposal to Support Transparency in Political Spending. OTHER SOCIAL ISSUES SECURITY HOLDER 21256.000000 0 AGAINST 21256.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: William H.L. Burnside DIRECTOR ELECTIONS ISSUER 103956.000000 0 FOR 103956.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Thomas C. Freyman DIRECTOR ELECTIONS ISSUER 103956.000000 0 FOR 103956.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Brett J. Hart DIRECTOR ELECTIONS ISSUER 103956.000000 0 FOR 103956.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Election of Class I Directors: Edward J. Rapp DIRECTOR ELECTIONS ISSUER 103956.000000 0 FOR 103956.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2025 AUDIT-RELATED ISSUER 103956.000000 0 FOR 103956.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Say on Pay - An advisory vote on the approval of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 103956.000000 0 AGAINST 103956.000000 AGAINST AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting CORPORATE GOVERNANCE ISSUER 103956.000000 0 FOR 103956.000000 FOR AbbVie Inc. 00287Y109 US00287Y1091 05/09/2025 Stockholder Proposal - to Implement Simple Majority Vote CORPORATE GOVERNANCE SECURITY HOLDER 103956.000000 0 FOR 103956.000000 AGAINST Lonza Group AG H50524133 CH0013841017 05/09/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Non-Financial Report CORPORATE GOVERNANCE ENVIRONMENT OR CLIMATE HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Remuneration Report COMPENSATION ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Allocation of Income and Dividends of CHF 4.00 per Share CAPITAL STRUCTURE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Marion Helmes as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Jean-Marc Huet as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Angelica Kohlmann as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Christoph Maeder as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Roger Nitsch as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Barbara Richmond as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Juergen Steinemann as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Elect Juan Andres as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Elect Eric Drape as Director (from May 14, 2025) DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Elect David Meline as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reelect Jean-Marc Huet as Board Chair DIRECTOR ELECTIONS ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reappoint Angelica Kohlmann as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reappoint Christoph Maeder as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Reappoint Juergen Steinemann as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Appoint Eric Drape as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Appoint David Meline as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Ratify Deloitte AG as Auditors for Fiscal Year 2025 AUDIT-RELATED ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Designate Lenz Caemmerer as Independent Proxy CORPORATE GOVERNANCE ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Remuneration of Directors in the Amount of CHF 4.3 Million COMPENSATION ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Variable Short-Term Remuneration of Executive Committee in the Amount of CHF 5.1 Million COMPENSATION ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Approve Fixed and Variable Long-Term Remuneration of Executive Committee in the Amount of CHF 25.6 Million COMPENSATION ISSUER 0.000000 0 Lonza Group AG H50524133 CH0013841017 05/09/2025 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 0.000000 0 Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Susan W. Brooks DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Ronald L. Burgess, Jr. DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: John A. Clerico DIRECTOR ELECTIONS ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Michael Dinkins DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: James S. Ely III DIRECTOR ELECTIONS ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: John A. Fry DIRECTOR ELECTIONS ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Joseph A. Hastings, D.M.D. DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Tim L. Hingtgen DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Elizabeth T. Hirsch DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: William Norris Jennings, M.D. DIRECTOR ELECTIONS ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: K. Ranga Krishnan, MBBS DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Fawn D. Lopez DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: Wayne T. Smith DIRECTOR ELECTIONS ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Election of Directors: H. James Williams, Ph.D. DIRECTOR ELECTIONS ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors on March 12, 2025, subject to stockholder approval. COMPENSATION ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to approve the amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc., to permit exculpation of officers. CORPORATE GOVERNANCE ISSUER 182950.000000 0 FOR 182950.000000 FOR Community Health Systems, Inc. 203668108 US2036681086 05/13/2025 Proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 182950.000000 0 AGAINST 182950.000000 AGAINST Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the annual report and accounts for the year ended December 31, 2024, together with the directors' report and independent auditor's report thereon, be received and adopted. CORPORATE GOVERNANCE ISSUER 1681804.000000 0 FOR 1681804.000000 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That PricewaterhouseCoopers LLP ("PwC") be re-appointed as auditors to hold office from the conclusion of the annual general meeting until the conclusion of the next annual general meeting at which the Company's annual report and accounts are presented. AUDIT-RELATED ISSUER 1681804.000000 0 FOR 1681804.000000 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the Audit and Risk Committee be authorized to determine PwC's remuneration. AUDIT-RELATED ISSUER 1681804.000000 0 FOR 1681804.000000 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the directors' remuneration report (excluding the directors' remuneration policy), as set out in the Company's annual report and accounts for the year ended December 31, 2024, be approved. COMPENSATION ISSUER 1681804.000000 0 FOR 1681804.000000 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 1681804.000000 0 FOR 1681804.000000 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 1681804.000000 0 ONE YEAR 1681804.000000 AGAINST Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That Dr. Deepika Pakianathan be re-appointed as a director of the Company. DIRECTOR ELECTIONS ISSUER 1681804.000000 0 AGAINST 1681804.000000 AGAINST Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That Dr. Pierre Jacquet be re-appointed as a director of the Company. DIRECTOR ELECTIONS ISSUER 1681804.000000 0 FOR 1681804.000000 FOR Mereo BioPharma Group Plc 589492107 US5894921072 05/13/2025 That Michael Wyzga be re-appointed as a director of the Company. DIRECTOR ELECTIONS ISSUER 1681804.000000 0 AGAINST 1681804.000000 AGAINST Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Melody C. Barnes DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Theodore R. Bigman DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Debra A. Cafaro DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Michael J. Embler DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Matthew J. Lustig DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Roxanne M. Martino DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Marguerite M. Nader DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Sean P. Nolan DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Walter C. Rakowich DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Joe V. Rodriguez, Jr. DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Sumit Roy DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Election of Directors of Ventas, Inc.: Maurice S. Smith DIRECTOR ELECTIONS ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Approval, on an advisory basis, of the compensation of named executive officers of Ventas, Inc. SECTION 14A SAY-ON-PAY VOTES ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Ratification of the selection of KPMG LLP as independent registered public accounting firm of Ventas, Inc. for fiscal year 2025. AUDIT-RELATED ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Approval of an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to increase the number of authorized shares of common stock. CAPITAL STRUCTURE ISSUER 111734.000000 0 FOR 111734.000000 FOR Ventas, Inc. 92276F100 US92276F1003 05/13/2025 Approval of an amendment to the Amended and Restated Certificate of Incorporation of Ventas, Inc. to limit the liability of certain officers as permitted by Delaware Law. CORPORATE GOVERNANCE ISSUER 111734.000000 0 FOR 111734.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Election of Directors: Susan D. DeVore DIRECTOR ELECTIONS ISSUER 21194.000000 0 FOR 21194.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Election of Directors: Bahija Jallal DIRECTOR ELECTIONS ISSUER 21194.000000 0 FOR 21194.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Election of Directors: Ryan M. Schneider DIRECTOR ELECTIONS ISSUER 21194.000000 0 FOR 21194.000000 FOR Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 21194.000000 0 AGAINST 21194.000000 AGAINST Elevance Health, Inc. 036752103 US0367521038 05/14/2025 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 21194.000000 0 AGAINST 21194.000000 AGAINST Elevance Health, Inc. 036752103 US0367521038 05/14/2025 Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts. DIVERSITY, EQUITY, AND INCLUSION SECURITY HOLDER 21194.000000 0 AGAINST 21194.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Jeffrey M. Busch DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Matthew Cypher DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Ronald Marston DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Henry E. Cole DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Zhang Huiqi DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Paula R. Crowley DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To elect each of the following nominees to serve as director until the next annual meeting of stockholders and until her or his successor is duly elected and qualifies: Lori Wittman DIRECTOR ELECTIONS ISSUER 143229.000000 0 FOR 143229.000000 FOR Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 Advisory vote to approve the compensation of the Company's named executive officers as described in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 143229.000000 0 AGAINST 143229.000000 AGAINST Global Medical REIT Inc. 37954A204 US37954A2042 05/14/2025 To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 143229.000000 0 FOR 143229.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Allocation of Income and Dividends of EUR 0.90 per Share CAPITAL STRUCTURE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Transaction with bioMerieux India Pvt Ltd CORPORATE GOVERNANCE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Reelect Marie-Paule Kieny as Director DIRECTOR ELECTIONS ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Reelect Fanny Letier as Director DIRECTOR ELECTIONS ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Remuneration Policy of Corporate Officers COMPENSATION ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Remuneration Policy of CEO COMPENSATION ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Remuneration Policy of Directors COMPENSATION ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Compensation of Alexandre Merieux, Chairman of the Board COMPENSATION ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Compensation of Pierre Boulud, CEO COMPENSATION ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Amended Share Purchase Program (MyShare 2025) Reserved for Beneficiaries Employed in the State of California, USA OTHER Company-specific matter ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Decrease in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights (Rights Issue) up to Aggregate Nominal Amount of EUR 4,210,280 CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Approve Issuance of Equity or Equity-Linked Securities up to 20 Percent of Issued Capital for Private Placements CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 4,210,280 CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 18, 19, and 20 CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Capitalization of Reserves of Up to EUR 4,210,280 for Bonus Issue or Increase in Par Value CAPITAL STRUCTURE ISSUER 10310.000000 0 FOR 10310.000000 FOR bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Issuance of Equity Upon Conversion of a Subsidiary's Equity-Linked Securities without Preemptive Rights for Up to EUR 4,210,280 CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Set Total Limit for Capital Increase to Result from All Issuance Requests at EUR 4,210,280 CAPITAL STRUCTURE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Amend Articles of Bylaws CORPORATE GOVERNANCE ISSUER 10310.000000 0 AGAINST 10310.000000 AGAINST bioMerieux SA F1149Y232 FR0013280286 05/15/2025 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 10310.000000 0 FOR 10310.000000 FOR BioNTech SE 09075V102 US09075V1026 05/16/2025 Approve Allocation of Income and Omission of Dividends CAPITAL STRUCTURE ISSUER 72420.000000 0 FOR 72420.000000 FOR BioNTech SE 09075V102 US09075V1026 05/16/2025 Approve Discharge of Management Board for Fiscal Year 2024 CORPORATE GOVERNANCE ISSUER 72420.000000 0 FOR 72420.000000 FOR BioNTech SE 09075V102 US09075V1026 05/16/2025 Approve Discharge of Supervisory Board for Fiscal Year 2024 CORPORATE GOVERNANCE ISSUER 72420.000000 0 FOR 72420.000000 FOR BioNTech SE 09075V102 US09075V1026 05/16/2025 Ratify EY GmbH & Co. KG as Auditors for Fiscal Year 2025 AUDIT-RELATED ISSUER 72420.000000 0 FOR 72420.000000 FOR BioNTech SE 09075V102 US09075V1026 05/16/2025 Appoint EY GmbH & Co. KG as Auditor for Sustainability Reporting for Fiscal Year 2025 AUDIT-RELATED ISSUER 72420.000000 0 FOR 72420.000000 FOR BioNTech SE 09075V102 US09075V1026 05/16/2025 Approve Remuneration Report COMPENSATION ISSUER 72420.000000 0 AGAINST 72420.000000 AGAINST BioNTech SE 09075V102 US09075V1026 05/16/2025 Approve Creation of EUR 124.3 Million Pool of Authorized Capital with or without Exclusion of Preemptive Rights CAPITAL STRUCTURE ISSUER 72420.000000 0 AGAINST 72420.000000 AGAINST Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Nancy H. Agee DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Thomas N. Bohjalian DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Ajay Gupta DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: David B. Henry DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: James J. Kilroy DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Jay P. Leupp DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Peter F. Lyle DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Constance B. Moore DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Glenn Rufrano DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Christann M. Vasquez DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 Election of Directors: Donald C. Wood DIRECTOR ELECTIONS ISSUER 149567.000000 0 FOR 149567.000000 FOR Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 To ratify the appointment of BDO USA, P.C. as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2025 fiscal year. AUDIT-RELATED ISSUER 149567.000000 0 AGAINST 149567.000000 AGAINST Healthcare Realty Trust Incorporated 42226K105 US42226K1051 05/20/2025 To approve, on a non-binding advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the Company's proxy statement for the 2025 Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES ISSUER 149567.000000 0 FOR 149567.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Adoption of Merus N.V.'s Dutch statutory annual accounts for the financial year 2024. CORPORATE GOVERNANCE ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2025 for purposes of Dutch law. AUDIT-RELATED ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2024. CORPORATE GOVERNANCE ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors. CORPORATE GOVERNANCE ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Re-appointment of Anand Mehra, M.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Opportunity to make recommendations for nomination by Merus N.V.'s group of non-executive directors. CORPORATE GOVERNANCE ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Re-appointment of Maxine Gowen, Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Granting authorization to Merus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital. CAPITAL STRUCTURE ISSUER 88903.000000 0 FOR 88903.000000 FOR Merus N.V. N5749R100 NL0011606264 05/21/2025 Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 88903.000000 0 AGAINST 88903.000000 AGAINST National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of Directors. Nominees RECOMMENDED by the Company: Robert G. Adams DIRECTOR ELECTIONS ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of Directors. Nominees RECOMMENDED by the Company: Robert W. Chapin, Jr. DIRECTOR ELECTIONS ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of Directors. Nominees RECOMMENDED by the Company: James R. Jobe DIRECTOR ELECTIONS ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of Directors. Nominees RECOMMENDED by the Company: Candice W. Todd DIRECTOR ELECTIONS ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of Directors. Dissident Nominees OPPOSED by the Company: James Hoffmann DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of Directors. Dissident Nominees OPPOSED by the Company: A. Adam Troso DIRECTOR ELECTIONS SECURITY HOLDER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Approve an amendment to the Company's Articles of Incorporation, as amended, to declassify the Board of Directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Approve, on a non-binding advisory basis, the compensation paid to our named executive officers as disclosed in the accompanying Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Ratify the audit committee's selection of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 0.000000 0 National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. LAND & BUILDINGS NOMINEES: James Hoffmann DIRECTOR ELECTIONS SECURITY HOLDER 4442.000000 0 FOR 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. LAND & BUILDINGS NOMINEES: A. Adam Troso DIRECTOR ELECTIONS SECURITY HOLDER 4442.000000 0 FOR 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES UNOPPOSED BY LAND & BUILDINGS NOMINEES: Candice W. Todd DIRECTOR ELECTIONS ISSUER 4442.000000 0 FOR 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES UNOPPOSED BY LAND & BUILDINGS NOMINEES: Robert W. Chapin, Jr. DIRECTOR ELECTIONS ISSUER 4442.000000 0 FOR 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES OPPOSED BY LAND & BUILDINGS NOMINEES: Robert G. Adams DIRECTOR ELECTIONS ISSUER 4442.000000 0 WITHHOLD 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 Election of four (4) directors for the applicable term as set forth in the proxy statement* or until their successors are duly elected and qualified. COMPANY NOMINEES OPPOSED BY LAND & BUILDINGS NOMINEES: James R. Jobe DIRECTOR ELECTIONS ISSUER 4442.000000 0 WITHHOLD 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 The Company's proposal to approve an amendment to the Company's Articles of Incorporation, as amended, to declassify the Board. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 4442.000000 0 FOR 4442.000000 FOR National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 The Company's proposal to approve, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4442.000000 0 FOR 4442.000000 NONE National Health Investors, Inc. 63633D104 US63633D1046 05/21/2025 The Company's proposal to ratify the Audit Committee's selection of BDO USA, P.C. as the Company's independent registered public accounting firm for fiscal year 2025. AUDIT-RELATED ISSUER 4442.000000 0 FOR 4442.000000 NONE Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Marc N. Casper DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Nelson J. Chai DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Ruby R. Chandy DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: C. Martin Harris DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Tyler Jacks DIRECTOR ELECTIONS ISSUER 21972.000000 0 AGAINST 21972.000000 AGAINST Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Jennifer M. Johnson DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: R. Alexandra Keith DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Karen S. Lynch DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: James C. Mullen DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Debora L. Spar DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Scott M. Sperling DIRECTOR ELECTIONS ISSUER 21972.000000 0 AGAINST 21972.000000 AGAINST Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Election of Directors: Dion J. Weisler DIRECTOR ELECTIONS ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 An advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 21972.000000 0 AGAINST 21972.000000 AGAINST Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2025. AUDIT-RELATED ISSUER 21972.000000 0 FOR 21972.000000 FOR Thermo Fisher Scientific Inc. 883556102 US8835561023 05/21/2025 Shareholder proposal. CORPORATE GOVERNANCE SECURITY HOLDER 21972.000000 0 AGAINST 21972.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Paul M. Bisaro DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Vanessa Broadhurst DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Frank A. D'Amelio DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Gavin D.K. Hattersley DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Sanjay Khosla DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Antoinette R. Leatherberry DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Michael B. McCallister DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Gregory Norden DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Louise M. Parent DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Kristin C. Peck DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Willie M. Reed DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Election of Directors: Mark Stetter DIRECTOR ELECTIONS ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 37056.000000 0 AGAINST 37056.000000 AGAINST Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 37056.000000 0 FOR 37056.000000 FOR Zoetis Inc. 98978V103 US98978V1035 05/21/2025 Shareholder proposal regarding a special shareholder meeting improvement. CORPORATE GOVERNANCE SECURITY HOLDER 37056.000000 0 AGAINST 37056.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/22/2025 Election of Directors: Jessica Hopfield DIRECTOR ELECTIONS ISSUER 6573.000000 0 FOR 6573.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/22/2025 Election of Directors: Ashley A. McEvoy DIRECTOR ELECTIONS ISSUER 6573.000000 0 FOR 6573.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/22/2025 Election of Directors: Elizabeth H. Weatherman DIRECTOR ELECTIONS ISSUER 6573.000000 0 FOR 6573.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/22/2025 To approve, on a non-binding, advisory basis, the compensation of certain executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 6573.000000 0 AGAINST 6573.000000 AGAINST Insulet Corporation 45784P101 US45784P1012 05/22/2025 To approve the Insulet Corporation 2025 Stock Option and Incentive Plan. COMPENSATION ISSUER 6573.000000 0 FOR 6573.000000 FOR Insulet Corporation 45784P101 US45784P1012 05/22/2025 To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 6573.000000 0 FOR 6573.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Kenneth J. Bacon DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Karen B. DeSalvo DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Andrew Gundlach DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Dennis G. Lopez DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Shankh Mitra DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Ade J. Patton DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Sergio D. Rivera DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Johnese M. Spisso DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 Election of Directors: Kathryn M. Sullivan DIRECTOR ELECTIONS ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 The ratification of the selection of Ernst & Young LLP as Welltower Inc.'s independent registered public accounting firm for the year ending December 31, 2025. AUDIT-RELATED ISSUER 38266.000000 0 AGAINST 38266.000000 AGAINST Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 The approval, on an advisory basis, of the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 38266.000000 0 FOR 38266.000000 FOR Welltower Inc. 95040Q104 US95040Q1040 05/22/2025 The approval of the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. COMPENSATION ISSUER 38266.000000 0 FOR 38266.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr. DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2026 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles DIRECTOR ELECTIONS ISSUER 28228.000000 0 FOR 28228.000000 FOR Amgen Inc. 031162100 US0311621009 05/23/2025 Advisory vote to approve our executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 28228.000000 0 AGAINST 28228.000000 AGAINST Amgen Inc. 031162100 US0311621009 05/23/2025 To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 28228.000000 0 AGAINST 28228.000000 AGAINST argenx SE 04016X101 US04016X1019 05/27/2025 Approve Remuneration Report COMPENSATION ISSUER 8970.000000 0 AGAINST 8970.000000 AGAINST argenx SE 04016X101 US04016X1019 05/27/2025 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 8970.000000 0 FOR 8970.000000 FOR argenx SE 04016X101 US04016X1019 05/27/2025 Approve Allocation of Income to the Retained Earnings of the Company CAPITAL STRUCTURE ISSUER 8970.000000 0 FOR 8970.000000 FOR argenx SE 04016X101 US04016X1019 05/27/2025 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 8970.000000 0 FOR 8970.000000 FOR argenx SE 04016X101 US04016X1019 05/27/2025 Approve Remuneration Policy COMPENSATION ISSUER 8970.000000 0 AGAINST 8970.000000 AGAINST argenx SE 04016X101 US04016X1019 05/27/2025 Reelect Anthony Rosenberg as Non-Executive Director DIRECTOR ELECTIONS ISSUER 8970.000000 0 FOR 8970.000000 FOR argenx SE 04016X101 US04016X1019 05/27/2025 Grant Board Authority to Issue Shares and Exclude Pre-emptive Rights CAPITAL STRUCTURE ISSUER 8970.000000 0 FOR 8970.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Elect Lars Luthjohan as Chair of Meeting CORPORATE GOVERNANCE ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Albert Cha as Director DIRECTOR ELECTIONS ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Lars Holtug as Director DIRECTOR ELECTIONS ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Jan Moller Mikkelsen as Director DIRECTOR ELECTIONS ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Lisa Jane Morrison as Director DIRECTOR ELECTIONS ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect William Carl Fairey Jr as Director DIRECTOR ELECTIONS ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Reelect Siham Imani as Director DIRECTOR ELECTIONS ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Ratify Deloitte as Auditor AUDIT-RELATED ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Approve Creation of DKK 3.8 Million Pool of Capital without Preemptive Rights CAPITAL STRUCTURE ISSUER 27668.000000 0 FOR 27668.000000 FOR Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Approve Issuance of Warrants to Board Members COMPENSATION ISSUER 27668.000000 0 AGAINST 27668.000000 AGAINST Ascendis Pharma A/S 04351P101 US04351P1012 05/27/2025 Amend Articles Re: Board-Related CORPORATE GOVERNANCE ISSUER 27668.000000 0 FOR 27668.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Douglas M. Baker, Jr. DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Mary Ellen Coe DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Pamela J. Craig DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Robert M. Davis DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Thomas H. Glocer DIRECTOR ELECTIONS ISSUER 167280.000000 0 AGAINST 167280.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Surendralal L. Karsanbhai DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Risa J. Lavizzo-Mourey, M.D. DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Stephen L. Mayo, Ph.D. DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Paul B. Rothman, M.D. DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Patricia F. Russo DIRECTOR ELECTIONS ISSUER 167280.000000 0 AGAINST 167280.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Christine E. Seidman, M.D. DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Inge G. Thulin DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Election of Directors: Kathy J. Warden DIRECTOR ELECTIONS ISSUER 167280.000000 0 FOR 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Non-binding advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 167280.000000 0 AGAINST 167280.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Ratification of the appointment of the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 167280.000000 0 AGAINST 167280.000000 AGAINST Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a human rights impact assessment. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 167280.000000 0 AGAINST 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a tax transparency report. OTHER SOCIAL ISSUES SECURITY HOLDER 167280.000000 0 AGAINST 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal to revisit DEl goals in executive pay incentives. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 167280.000000 0 AGAINST 167280.000000 FOR Merck & Co., Inc. 58933Y105 US58933Y1055 05/27/2025 Shareholder proposal regarding a report on civil liberties in advertising services. ENVIRONMENT OR CLIMATE DIVERSITY, EQUITY, AND INCLUSION OTHER SOCIAL ISSUES SECURITY HOLDER 167280.000000 0 AGAINST 167280.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Cornelia Cheng DIRECTOR ELECTIONS ISSUER 63514.000000 0 FOR 63514.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: David L. Gruber DIRECTOR ELECTIONS ISSUER 63514.000000 0 FOR 63514.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Jeffrey C. Hawken DIRECTOR ELECTIONS ISSUER 63514.000000 0 FOR 63514.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Bradley J. Preber DIRECTOR ELECTIONS ISSUER 63514.000000 0 FOR 63514.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Wendy L. Simpson DIRECTOR ELECTIONS ISSUER 63514.000000 0 FOR 63514.000000 FOR LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Election of Directors: Six directors will be elected to hold office until the 2026 Annual Meeting of Stockholders, and in each case, until their respective successors have been duly elected and qualified: Timothy J. Triche DIRECTOR ELECTIONS ISSUER 63514.000000 0 AGAINST 63514.000000 AGAINST LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 63514.000000 0 AGAINST 63514.000000 AGAINST LTC Properties, Inc. 502175102 US5021751020 05/28/2025 Ratification of independent registered public accounting firm. AUDIT-RELATED ISSUER 63514.000000 0 AGAINST 63514.000000 AGAINST LTC Properties, Inc. 502175102 US5021751020 05/28/2025 To approve the amendment and restatement of our company's Charter to increase the number of authorized shares of common stock from 60,000,000 shares to 110,000,000 shares. CAPITAL STRUCTURE ISSUER 63514.000000 0 FOR 63514.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Independent Trustee): Alan Felder DIRECTOR ELECTIONS ISSUER 63841.000000 0 FOR 63841.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Independent Trustee): Lisa Harris Jones DIRECTOR ELECTIONS ISSUER 63841.000000 0 WITHHOLD 63841.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Independent Trustee): Phyllis M. Hollis DIRECTOR ELECTIONS ISSUER 63841.000000 0 FOR 63841.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Independent Trustee): Dawn K. Neher DIRECTOR ELECTIONS ISSUER 63841.000000 0 FOR 63841.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Independent Trustee): Jeffrey P. Somers DIRECTOR ELECTIONS ISSUER 63841.000000 0 WITHHOLD 63841.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Managing Trustee): Christopher J. Bilotto DIRECTOR ELECTIONS ISSUER 63841.000000 0 FOR 63841.000000 FOR Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Election of Trustees: Nominees (for Managing Trustee): Adam Portnoy DIRECTOR ELECTIONS ISSUER 63841.000000 0 WITHHOLD 63841.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Advisory vote to approve executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 63841.000000 0 AGAINST 63841.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Approval of the Diversified Healthcare Trust Second Amended and Restated 2012 Equity Compensation Plan. COMPENSATION ISSUER 63841.000000 0 AGAINST 63841.000000 AGAINST Diversified Healthcare Trust 25525P107 US25525P1075 05/29/2025 Ratification of the appointment of Deloitte & Touche LLP as independent auditors to serve for the 2025 fiscal year. AUDIT-RELATED ISSUER 63841.000000 0 FOR 63841.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: Edward K. Aldag, Jr. DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: G. Steven Dawson DIRECTOR ELECTIONS ISSUER 145186.000000 0 AGAINST 145186.000000 AGAINST Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: R. Steven Hamner DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: Caterina A. Mozingo DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: Emily W. Murphy DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: Elizabeth N. Pitman DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: D. Paul Sparks, Jr. DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: Michael G. Stewart DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To elect nine directors: C. Reynolds Thompson, III DIRECTOR ELECTIONS ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 145186.000000 0 FOR 145186.000000 FOR Medical Properties Trust, Inc. 58463J304 US58463J3041 05/29/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 145186.000000 0 AGAINST 145186.000000 AGAINST UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Charles Baker DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Timothy Flynn DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Paul Garcia DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Kristen Gil DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Stephen Hemsley DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Michele Hooper DIRECTOR ELECTIONS ISSUER 60767.000000 0 AGAINST 60767.000000 AGAINST UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: F. William McNabb III DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: Valerie Montgomery Rice, M.D. DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Election of Directors: John Noseworthy, M.D. DIRECTOR ELECTIONS ISSUER 60767.000000 0 FOR 60767.000000 FOR UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Advisory approval of the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 60767.000000 0 AGAINST 60767.000000 AGAINST UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025. AUDIT-RELATED ISSUER 60767.000000 0 AGAINST 60767.000000 AGAINST UnitedHealth Group Incorporated 91324P102 US91324P1021 06/02/2025 If properly presented at the 2025 Annual Meeting of Shareholders, the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. COMPENSATION SECURITY HOLDER 60767.000000 0 AGAINST 60767.000000 FOR ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Approve Financial Statements and Allocation of Income CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 1850348.000000 0 FOR 1850348.000000 FOR ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Approve Discharge of Management and Supervisory Boards CORPORATE GOVERNANCE ISSUER 1850348.000000 0 FOR 1850348.000000 FOR ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Reelect James Shannon as Non-Executive Director DIRECTOR ELECTIONS ISSUER 1850348.000000 0 AGAINST 1850348.000000 AGAINST ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Reelect Daniel de Boer as Executive Director DIRECTOR ELECTIONS ISSUER 1850348.000000 0 FOR 1850348.000000 FOR ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Ratify KPMG Accountants N.V. as Auditors AUDIT-RELATED ISSUER 1850348.000000 0 FOR 1850348.000000 FOR ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Grant Board Authority to Issue Shares CAPITAL STRUCTURE ISSUER 1850348.000000 0 FOR 1850348.000000 FOR ProQR Therapeutics NV N71542109 NL0010872495 06/03/2025 Authorize Board to Repurchase Shares CAPITAL STRUCTURE ISSUER 1850348.000000 0 FOR 1850348.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Instruction to Deloitte Accountants B.V. as the Company's external auditor of the Company's Dutch statutory annual accounts and Dutch statutory board report for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Ratification of the selection of Deloitte Accountants B.V. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025 by the audit committee of the Company's Board of Directors. AUDIT-RELATED ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Appointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Wouter Joustra DIRECTOR ELECTIONS ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Appointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Mark McKenna DIRECTOR ELECTIONS ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Appointment of the following individuals as non-executive directors of the Company until the annual general meeting set forth next to their name: Adele Gulfo DIRECTOR ELECTIONS ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Reappointment of Michael Davidson M.D. as executive director and Dr. James N. Topper as non-executive director of the Company until the 2029 annual general meeting: Michael Davidson DIRECTOR ELECTIONS ISSUER 262912.000000 0 AGAINST 262912.000000 AGAINST NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Reappointment of Michael Davidson M.D. as executive director and Dr. James N. Topper as non-executive director of the Company until the 2029 annual general meeting: James N. Topper DIRECTOR ELECTIONS ISSUER 262912.000000 0 AGAINST 262912.000000 AGAINST NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Extension of authorization for the Board of Directors to acquire ordinary shares and depository receipts for ordinary shares in the Company's capital. CAPITAL STRUCTURE ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Non-binding, advisory vote to approve the 2024 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 262912.000000 0 FOR 262912.000000 FOR NewAmsterdam Pharma Company N.V. N62509109 NL00150012L7 06/04/2025 Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 262912.000000 0 ONE YEAR 262912.000000 FOR Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Treatment of Net Loss CAPITAL STRUCTURE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Discharge of Board and Senior Management CORPORATE GOVERNANCE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Anthony Rosenberg as Director and Board Chair DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Christina Ackermann as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Lionel Carnot as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Arshad Khanani as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Martijn Kleijwegt as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Geraldine O'Keeffe as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Riad Sherif as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reelect Robert Warner as Director DIRECTOR ELECTIONS ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reappoint Christina Ackermann as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Reappoint Lionel Carnot as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Appoint Robert Warner as Member of the Compensation Committee DIRECTOR ELECTIONS CORPORATE GOVERNANCE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Ratify PricewaterhouseCoopers SA as Statutory Auditors AUDIT-RELATED ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Designate PST Legal AG as Independent Proxy CORPORATE GOVERNANCE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Fixed Remuneration of Directors in the Amount of USD 572,000 COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Equity-Based Remuneration of Directors in the Amount of USD 2.2 Million COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Fixed Remuneration of Executive Committee in the Amount of USD 2.5 Million COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Variable Remuneration of Executive Committee in the Amount of USD 1.8 Million COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Equity-Based Remuneration of Executive Committee in the Amount of USD 15.5 Million COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Remuneration Report (Non-Binding) COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Creation of Capital Band within the Upper Limit of CHF 818,005 and the Lower Limit of CHF 545,337 with or without Exclusion of Preemptive Rights CAPITAL STRUCTURE ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Approve Creation of CHF 124,800 Pool of Conditional Capital for Employee Equity Plans COMPENSATION ISSUER 0.000000 0 Oculis Holding AG H5870P102 CH1242303498 06/04/2025 Transact Other Business (Voting) CORPORATE GOVERNANCE ISSUER 0.000000 0 Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Approve Remuneration Report COMPENSATION ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Approve Remuneration Policy COMPENSATION ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Elect Daniel Mahony as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Sarah Fortune as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Adrian Hennah as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Nicholas Keher as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect John O'Higgins as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Heather Preston as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Katherine Priestman as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Gurdial Sanghera as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Re-elect Duncan Tatton-Brown as Director DIRECTOR ELECTIONS ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Reappoint Deloitte LLP as Auditors AUDIT-RELATED ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise the Audit & Risk Committee to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise Market Purchase of Ordinary Shares CAPITAL STRUCTURE ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Authorise UK Political Donations and Expenditure OTHER SOCIAL ISSUES ISSUER 784418.000000 0 FOR 784418.000000 FOR Oxford Nanopore Technologies Plc G6840E103 GB00BP6S8Z30 06/04/2025 Amend Long Term Incentive Plan COMPENSATION ISSUER 784418.000000 0 FOR 784418.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 ELECTION OF DIRECTORS: Chen Lichtenstein - to serve until Teva's 2027 Annual Meeting DIRECTOR ELECTIONS ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 ELECTION OF DIRECTORS: Amir Elstein - to serve until Teva's 2028 Annual Meeting DIRECTOR ELECTIONS ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 ELECTION OF DIRECTORS: Roberto A. Mignone to serve until Teva's 2028 Annual Meeting] DIRECTOR ELECTIONS ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 ELECTION OF DIRECTORS: Dr. Perry D. Nisen to serve until Teva's 2028 Annual Meeting DIRECTOR ELECTIONS ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 ELECTION OF DIRECTORS: Dr. Tal Zaks to serve until Teva's 2028 Annual Meeting DIRECTOR ELECTIONS ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION FOR TEVA'S NAMED EXECUTIVE OFFICERS SECTION 14A SAY-ON-PAY VOTES ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 TO APPROVE AN AMENDED COMPENSATION POLICY WITH RESPECT TO THE TERMS OF OFFICE AND EMPLOYMENT OF TEVA'S EXECUTIVE OFFICERS AND DIRECTORS* COMPENSATION ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 TO APPROVE AN AMENDMENT TO THE TERMS OF OFFICE AND EMPLOYMENT OF TEVA'S PRESIDENT AND CHIEF EXECUTIVE OFFICER COMPENSATION ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 TO APPROVE THE COMPENSATION TO BE PROVIDED TO TEVA'S NON-EMPLOYEE DIRECTORS COMPENSATION ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 TO APPROVE THE COMPENSATION TO BE PROVIDED TO TEVA'S NON-EXECUTIVE CHAIRMAN OF THE BOARD COMPENSATION ISSUER 584058.000000 0 FOR 584058.000000 FOR Teva Pharmaceutical Industries Limited 881624209 US8816242098 06/05/2025 TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS TEVA'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL TEVA'S 2026 ANNUAL MEETING OF SHAREHOLDERS AUDIT-RELATED ISSUER 584058.000000 0 FOR 584058.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Approve Treatment of Losses CAPITAL STRUCTURE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions CORPORATE GOVERNANCE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Ratify Appointment of Sylvie Gregoire as Director DIRECTOR ELECTIONS ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Ratify Appointment of Dominik Hochli as Director DIRECTOR ELECTIONS ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Reelect Corinna zur Bonsen-Thomas as Director DIRECTOR ELECTIONS ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Reelect Marc de Garidel as Director DIRECTOR ELECTIONS ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Reelect Camilla Soenderby as Director DIRECTOR ELECTIONS ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Reelect Dominik Hochli as Director DIRECTOR ELECTIONS ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Renew Appointment of PricewaterhouseCoopers Audit as Auditor AUDIT-RELATED ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Approve Compensation Report COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Compensation of Marc de Garidel, Acting Chairman of the Board and CEO COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Compensation of Sylvie Gregoire, Chairwoman of the Board COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Remuneration Policy of CEO COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Remuneration Policy of Directors COMPENSATION ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Decrease in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 223,822 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line on the American Market, up to Aggregate Nominal Amount of EUR 63,000 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 223,822 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Capitalization of Reserves of Up to EUR 750,000 for Bonus Issue or Increase in Par Value CAPITAL STRUCTURE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 21-26 and 29-30 at EUR 750,000 CAPITAL STRUCTURE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans COMPENSATION ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 32-34, at 10 Percent of Issued Capital CAPITAL STRUCTURE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 37000.000000 0 FOR 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Change Corporate Purpose and Amend Article 4 of Bylaws Accordingly CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Remove Article 6.1 of Bylaws CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Amend Article 15.2 of Bylaws Re: Board Meetings CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Amend Articles 15.3 and 17.1 of Bylaws Re: Quorum and Majority at Board Meetings CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Amend Articles 15.5 of Bylaws Re: Written Consultation CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA F00182109 FR0012333284 06/06/2025 Amend Articles 16.1 of Bylaws Re: Powers of the Board CORPORATE GOVERNANCE ISSUER 37000.000000 0 AGAINST 37000.000000 AGAINST Abivax SA F00182109 FR0012333284 06/06/2025 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 37000.000000 0 FOR 37000.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Consolidated Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Treatment of Losses CAPITAL STRUCTURE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions CORPORATE GOVERNANCE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Ratify Appointment of Sylvie Gregoire as Director DIRECTOR ELECTIONS ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Ratify Appointment of Dominik Hochli as Director DIRECTOR ELECTIONS ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Reelect Corinna zur Bonsen-Thomas as Director DIRECTOR ELECTIONS ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Reelect Marc de Garidel as Director DIRECTOR ELECTIONS ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Reelect Camilla Soenderby as Director DIRECTOR ELECTIONS ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Reelect Dominik Hochli as Director DIRECTOR ELECTIONS ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Renew Appointment of PricewaterhouseCoopers Audit as Auditor AUDIT-RELATED ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Compensation Report COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Compensation of Marc de Garidel, Acting Chairman of the Board and CEO SECTION 14A SAY-ON-PAY VOTES ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Compensation of Sylvie Gregoire, Chairwoman of the Board SECTION 14A SAY-ON-PAY VOTES ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Compensation Report of Corporate Officers COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Remuneration Policy of Chairman of the Board COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Remuneration Policy of CEO COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Remuneration Policy of Directors COMPENSATION ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Repurchase of Up to 10 Percent of Issued Share Capital CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Decrease in Share Capital via Cancellation of Repurchased Shares CAPITAL STRUCTURE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 223,822 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries in the Framework of an Equity Line on the American Market, up to Aggregate Nominal Amount of EUR 63,000 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 223,822 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Capitalization of Reserves of Up to EUR 750,000 for Bonus Issue or Increase in Par Value CAPITAL STRUCTURE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 21-26 and 29-30 at EUR 750,000 CAPITAL STRUCTURE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans COMPENSATION ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Set Total Limit for Capital Increase to Result from Issuance Requests Under Items 32-34, at 10 Percent of Issued Capital CAPITAL STRUCTURE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Capital Issuances for Use in Employee Stock Purchase Plans COMPENSATION ISSUER 710516.000000 0 FOR 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Change Corporate Purpose and Amend Article 4 of Bylaws Accordingly CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Remove Article 6.1 of Bylaws CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Amend Article 15.2 of Bylaws Re: Board Meetings CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Amend Articles 15.3 and 17.1 of Bylaws Re: Quorum and Majority at Board Meetings CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Amend Articles 15.5 of Bylaws Re: Written Consultation CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Abivax SA 00370M103 US00370M1036 06/06/2025 Amend Articles 16.1 of Bylaws Re: Powers of the Board CORPORATE GOVERNANCE ISSUER 710516.000000 0 AGAINST 710516.000000 AGAINST Abivax SA 00370M103 US00370M1036 06/06/2025 Authorize Filing of Required Documents/Other Formalities CORPORATE GOVERNANCE ISSUER 710516.000000 0 FOR 710516.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Kapila K. Anand DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Craig R. Callen DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Dr. Lisa C. Egbuonu-Davis DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Barbara B. Hill DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Kevin J. Jacobs DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: C. Taylor Pickett DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Stephen D. Plavin DIRECTOR ELECTIONS ISSUER 71075.000000 0 AGAINST 71075.000000 AGAINST Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Election of Directors: Burke W. Whitman DIRECTOR ELECTIONS ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Ratification of the selection of Ernst & Young LLP as our independent auditor for fiscal year 2025 AUDIT-RELATED ISSUER 71075.000000 0 AGAINST 71075.000000 AGAINST Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Approval, on an advisory basis, of executive compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 71075.000000 0 FOR 71075.000000 FOR Omega Healthcare Investors, Inc. 681936100 US6819361006 06/06/2025 Approval of the Amendment to our Charter to increase the number of authorized shares of our common stock CAPITAL STRUCTURE ISSUER 71075.000000 0 FOR 71075.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): J. Christopher Barry DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Francesco Bianchi DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Stacy Enxing Seng DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): William Kozy DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Vladimir Makatsaria DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Dr. Sharon O'Kane DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Susan Podlogar DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Todd Schermerhorn DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Brooke Story DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To elect, by separate resolutions, each of the following ten (10) directors for a term expiring at the AGM to be held in 2026 ("2026 AGM"): Peter Wilver DIRECTOR ELECTIONS ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers ("US Say on Pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 100563.000000 0 AGAINST 100563.000000 AGAINST LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan. COMPENSATION ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve the LivaNova PLC 2025 Director Incentive Award Plan. COMPENSATION ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies Act"), to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert any security into, shares in the Company up to an aggregate nominal amount of pounds10,904,831, provided that: (A) (unless previously revoked, varied or renewed by the Company) this authority will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this authority expires, make offers or agreements which would or might require shares in the Company to be allotted, or rights to subscribe for, or convert securities into, shares to be granted, after its expiry and the directors may allot shares or grant rights to subscribe for, or convert securities into, shares pursuant to such offers or agreements as if this authority had not expired; and (B) this authority replaces all subsisting authorities previously granted to the directors for the purposes of section 551 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect without prejudice to any allotment of shares or grant of rights already made, offered or agreed to be made under such authorities. CAPITAL STRUCTURE ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Special Resolution: Subject to the passing of resolution 6 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution 6, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash, in each case as if section 561 of the Companies Act (existing shareholders' pre-emption rights) did not apply to any such allotment or sale, provided that this power is limited to the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of pounds10,904,831, provided that: (A) (unless previously revoked, varied or renewed by the Company) this power will expire at the end of the next annual general meeting of the Company or, if earlier, the close of business on the date that is fifteen (15) months after the date on which this resolution is passed, save that the directors may, before this power expires, make offers or agreements which would or might require equity securities to be allotted and/or treasury shares to be sold after its expiry and the directors may allot equity securities and/or sell treasury shares pursuant to such offers or agreement as if this power had not expired; and (B) this power replaces (except for any power conferred by resolution 6) all subsisting powers previously granted to the directors for the purposes of section 570 of the Companies Act which, to the extent unused at the date of this resolution, are revoked with immediate effect, without prejudice to any allotment of equity securities already made, offered or agreed to be made under such powers. CAPITAL STRUCTURE ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's UK annual report (the "UK Annual Report") for the period ended December 31, 2024. COMPENSATION ISSUER 100563.000000 0 AGAINST 100563.000000 AGAINST LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To approve the directors' remuneration policy contained in the directors' remuneration report as set forth in the UK Annual Report for the period ended December 31, 2024. COMPENSATION ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2024, together with the reports of the directors and auditors thereon. CORPORATE GOVERNANCE ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"), as the Company's UK statutory auditor for 2025. AUDIT-RELATED ISSUER 100563.000000 0 FOR 100563.000000 FOR LivaNova Plc G5509L101 GB00BYMT0J19 06/11/2025 Ordinary Resolution: To authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. AUDIT-RELATED ISSUER 100563.000000 0 FOR 100563.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Accept Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Approve Remuneration Report COMPENSATION ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Elect Colin Bond as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Elect Lucinda Crabtree as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Elect Laurence Espinasse as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Roch Doliveux as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Dame Kay Davies as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Frank Mathias as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Robert Ghenchev as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Namrata Patel as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Heather Preston as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Re-elect Peter Soelkner as Director DIRECTOR ELECTIONS ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Reappoint PriceWaterhouseCoopers LLP as Auditors AUDIT-RELATED ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Authorise the Audit Committee to Fix Remuneration of Auditors AUDIT-RELATED ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Authorise Issue of Equity CAPITAL STRUCTURE ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Authorise Issue of Equity without Pre-emptive Rights CAPITAL STRUCTURE ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment CAPITAL STRUCTURE ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Amend the Borrowing Limit Under the Company's Articles of Association CAPITAL STRUCTURE OTHER Debt Related ISSUER 764722.000000 0 FOR 764722.000000 FOR Oxford Biomedica Plc G6836F189 GB00BDFBVT43 06/11/2025 Authorise the Company to Call General Meeting with Two Weeks' Notice CORPORATE GOVERNANCE ISSUER 764722.000000 0 FOR 764722.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Adoption of the 2024 Dutch statutory annual accounts for the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Discharge of liability of the members of the Board for their management during the fiscal year ended December 31, 2024. CORPORATE GOVERNANCE ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Reappointment of Robert Gut, M.D., Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Reappointment of Matthew Kapusta as executive director. DIRECTOR ELECTIONS ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Reappointment of Jeremy Springhorn, Ph.D. as non-executive director. DIRECTOR ELECTIONS ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Authorization of the Board to issue Ordinary Shares and grant rights to subscribe for Ordinary Shares. CAPITAL STRUCTURE ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Authorization of the Board to exclude or limit preemptive rights upon the issuance of Ordinary Shares. CAPITAL STRUCTURE ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Authorization of the Board to repurchase Ordinary Shares. CAPITAL STRUCTURE ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Appointment of KPMG as external auditor of the Company for the financial year 2025. AUDIT-RELATED ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Approval, on an advisory basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES ISSUER 704952.000000 0 FOR 704952.000000 FOR uniQure N.V. N90064101 NL0010696654 06/11/2025 Resolution to adopt the Amendment and Restatement of the 2014 Share Incentive Plan. COMPENSATION ISSUER 704952.000000 0 FOR 704952.000000 FOR Universal Health Realty Income Trust 91359E105 US91359E1055 06/11/2025 Election of Trustees: Michael Allan Domb DIRECTOR ELECTIONS ISSUER 8183.000000 0 FOR 8183.000000 FOR Universal Health Realty Income Trust 91359E105 US91359E1055 06/11/2025 Election of Trustees: James P. Morey DIRECTOR ELECTIONS ISSUER 8183.000000 0 FOR 8183.000000 FOR Universal Health Realty Income Trust 91359E105 US91359E1055 06/11/2025 Election of Trustees: Rebecca A. Guzman DIRECTOR ELECTIONS ISSUER 8183.000000 0 FOR 8183.000000 FOR Universal Health Realty Income Trust 91359E105 US91359E1055 06/11/2025 Advisory (nonbinding) vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 8183.000000 0 AGAINST 8183.000000 AGAINST Universal Health Realty Income Trust 91359E105 US91359E1055 06/11/2025 Proposal to ratify the selection of KPMG, LLP as the Trust's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 8183.000000 0 AGAINST 8183.000000 AGAINST Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Michael Barber DIRECTOR ELECTIONS ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Paul Clancy DIRECTOR ELECTIONS ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Daniel Levangie DIRECTOR ELECTIONS ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kevin Conroy DIRECTOR ELECTIONS ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Shacey Petrovic DIRECTOR ELECTIONS ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Kimberly Popovits DIRECTOR ELECTIONS ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To elect seven members of the Board of Directors to serve for one-year terms (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal): Katherine Zanotti DIRECTOR ELECTIONS ISSUER 55633.000000 0 AGAINST 55633.000000 AGAINST Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025. AUDIT-RELATED ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 55633.000000 0 AGAINST 55633.000000 AGAINST Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To approve the 2025 Omnibus Long-Term Incentive Plan. COMPENSATION ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To approve an Amendment to the 2010 Employee Stock Purchase Plan to add 4,000,000 shares of stock to the pool of shares available for purchase by employees. COMPENSATION ISSUER 55633.000000 0 FOR 55633.000000 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/12/2025 To vote on a shareholder proposal concerning the adoption of a director election resignation governance policy, if properly presented. CORPORATE GOVERNANCE SECURITY HOLDER 55633.000000 0 AGAINST 55633.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Craig A. Barbarosh DIRECTOR ELECTIONS ISSUER 200380.000000 0 AGAINST 200380.000000 AGAINST Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Katie Cusack DIRECTOR ELECTIONS ISSUER 200380.000000 0 FOR 200380.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Michael J. Foster DIRECTOR ELECTIONS ISSUER 200380.000000 0 AGAINST 200380.000000 AGAINST Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Lynne S. Katzmann DIRECTOR ELECTIONS ISSUER 200380.000000 0 FOR 200380.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Ann Kono DIRECTOR ELECTIONS ISSUER 200380.000000 0 FOR 200380.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Jeffrey A. Malehorn DIRECTOR ELECTIONS ISSUER 200380.000000 0 FOR 200380.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Election of Directors: Richard K. Matros DIRECTOR ELECTIONS ISSUER 200380.000000 0 FOR 200380.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 200380.000000 0 FOR 200380.000000 FOR Sabra Health Care REIT, Inc. 78573L106 US78573L1061 06/12/2025 Approval, on an advisory basis, of the compensation of Sabra's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 200380.000000 0 FOR 200380.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/13/2025 The Transaction Proposal - To consider and vote on a proposal to approve and adopt the Transaction Agreement, dated as of March 13, 2025, by and among Endo, Mallinckrodt plc, a public limited company incorporated in Ireland with registered number 522227 ("Mallinckrodt"), and Salvare Merger Sub LLC, a Delaware limited liability company and wholly owned subsidiary of Mallinckrodt ("Merger Sub"), as it may be amended, supplemented, or otherwise modified from time to time (the "Transaction Agreement"), including the plan of merger contained therein, and the transactions contemplated thereby (the "Transactions"), including the merger of Merger Sub with and into Endo, with Endo continuing as the surviving corporation (the "Business Combination"), which is further described in the sections of the accompanying joint proxy statement/prospectus (the "joint proxy statement/prospectus") entitled "The Transaction" and "The Transaction Agreement" beginning on page 111 and page 305, respectively, of the joint proxy statement/prospectus and a copy of which is attached as Annex B to the joint proxy statement/prospectus. EXTRAORDINARY TRANSACTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/13/2025 The Distributable Reserves Proposal - To consider and vote on, on a non-binding, advisory basis, a proposal to approve (i) the reduction of the entire amount (or such lesser amount as the directors of Mallinckrodt or the Irish High Court may determine) standing to the credit of Mallinckrodt's share premium account as at the date of the joint proxy statement/prospectus (being the first Mallinckrodt distributable reserves creation); and (ii) the reduction of the entire amount (or such lesser amount as the directors of Mallinckrodt or the Irish High Court may determine) standing to the credit of Mallinckrodt's share premium account following the consummation of the Business Combination, (including but not limited to the share premium arising from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement or the amounts credited to Mallinckrodt's share premium account upon the capitalization of any merger reserve or like reserve resulting from the issuance of Mallinckrodt ordinary shares pursuant to the Transaction Agreement) (being the second Mallinckrodt distributable reserves creation). CAPITAL STRUCTURE ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/13/2025 The Combination-Related Compensation Proposal - To consider and vote on, on a non-binding, advisory basis, a proposal to approve compensation that will or may become payable by Endo to its named executive officers in connection with the Transactions. SECTION 14A SAY-ON-PAY VOTES ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/13/2025 The Mallinckrodt Articles Amendment Proposals - To consider and vote on, on a non-binding, advisory basis, eight separate proposals to approve the following amendments to the Mallinckrodt articles of association, presented separately in accordance with the requirements of the United States Securities and Exchange Commission: Change in Mallinckrodt Capital Structure - To vary the authorized share capital of Mallinckrodt, including through the creation of a new class of preferred shares, the removal of pre-emption rights of certain shareholders over newly issued shares and the deletion of Article 174 of the existing Mallinckrodt constitution, which capped the total number of shares issuable pursuant to Mallinckrodt's management incentive plan at 10%, as shown in Annex K-2 of the joint proxy statement/prospectus; CAPITAL STRUCTURE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Dealings in Transfers and Registration of Mallinckrodt Shares - To delete certain restrictions on Mallinckrodt shareholders' ability to deal in their Mallinckrodt shares, amend the circumstances in which directors can decline to register a transfer of shares and eliminate the drag-along rights and tag-along rights in the existing memorandum and articles of association of Mallinckrodt, as shown in Annex K-3 of the joint proxy statement/prospectus; SHAREHOLDER RIGHTS AND DEFENSES CAPITAL STRUCTURE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Change in Mallinckrodt Shareholder Meeting Procedure - To change the quorum required for general meetings (to two or more persons holding (or representing by proxy) at least one half in nominal value of the issued shares of an applicable class), the manner in which voting will be conducted (by requiring voting to be carried out by way of a poll) and the procedures required for advance notice of members' business and nominations (by aligning with the customary current approach by U.S. listed companies), as shown in Annex K-4 of the joint proxy statement/prospectus: CORPORATE GOVERNANCE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Transactions involving Mallinckrodt - To delete the ability of holders of more than one half of the Mallinckrodt shares to require the Mallinckrodt board to initiate a process for a review of strategic alternatives and a sale of assets or business segments, to delete restrictions on the Mallinckrodt board from selling, leasing or exchanging all or substantially all of Mallinckrodt's property and assets without prior consent of the holders of more than one half of the Mallinckrodt shares, to amend provisions regarding shareholder rights plan to align with the customary approach adopted by Irish incorporated U.S. listed companies and to restrict Mallinckrodt from engaging in business combinations with "interested members" for a period of time, subject to certain exceptions, as shown in Annex K-5 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Proceedings of Mallinckrodt Directors - To permit the Mallinckrodt board to determine its own size (subject to a minimum of two and a maximum of twenty directors) and its own chair, and to allow for the vacation ipso facto of the office of a director where he or she is requested to resign in writing by not less than three quarters of the other directors, as shown in Annex K-6 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Appointment and Removal of Mallinckrodt Directors - To change the provisions regarding appointment of Mallinckrodt directors and add provisions regarding plurality voting of directors, as shown in Annex K-7 of the joint proxy statement/prospectus; CORPORATE GOVERNANCE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Information Rights and Board Observers - To delete existing provisions in respect of information rights and board observers for certain shareholders, as shown in Annex K-8 of the joint proxy statement/prospectus; and CORPORATE GOVERNANCE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Endo, Inc. 29290D117 US29290D1173 06/13/2025 Miscellaneous Changes - To make certain other changes to make Mallinckrodt's articles of association in a form that is customary for an Irish public limited company effecting a transaction of the nature of the Transactions and for a potential listing of Mallinckrodt's shares on the New York Stock Exchange, as shown in Annex K-9 of the joint proxy statement/prospectus. CORPORATE GOVERNANCE ISSUER 30.000000 0 AGAINST 30.000000 AGAINST Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Bonnie L. Bassler, Ph.D. DIRECTOR ELECTIONS ISSUER 7786.000000 0 AGAINST 7786.000000 AGAINST Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Michael S. Brown, M.D. DIRECTOR ELECTIONS ISSUER 7786.000000 0 AGAINST 7786.000000 AGAINST Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: Leonard S. Schleifer, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 7786.000000 0 FOR 7786.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Election of Directors: George D. Yancopoulos, M.D., Ph.D. DIRECTOR ELECTIONS ISSUER 7786.000000 0 FOR 7786.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 7786.000000 0 FOR 7786.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Proposal to approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7786.000000 0 FOR 7786.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Proposal to approve an amendment to the Company's Certificate of Incorporation to declassify the board of directors. SHAREHOLDER RIGHTS AND DEFENSES ISSUER 7786.000000 0 FOR 7786.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article IV, Section 2(e)(8) of the Certificate of Incorporation CORPORATE GOVERNANCE ISSUER 7786.000000 0 FOR 7786.000000 FOR Regeneron Pharmaceuticals, Inc. 75886F107 US75886F1075 06/13/2025 Amendments to the Company's Certificate of Incorporation to Eliminate Supermajority Vote Requirements Proposal to approve an amendment to Article VI of the Certificate of Incorporation. CORPORATE GOVERNANCE ISSUER 7786.000000 0 FOR 7786.000000 FOR Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: David Mott DIRECTOR ELECTIONS ISSUER 409796.000000 0 WITHHOLD 409796.000000 AGAINST Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: Michael Raab DIRECTOR ELECTIONS ISSUER 409796.000000 0 FOR 409796.000000 FOR Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES ISSUER 409796.000000 0 FOR 409796.000000 FOR Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To ratify the selection, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025; AUDIT-RELATED ISSUER 409796.000000 0 FOR 409796.000000 FOR Ardelyx, Inc. 039697107 US0396971071 06/18/2025 To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan; and COMPENSATION ISSUER 409796.000000 0 AGAINST 409796.000000 AGAINST Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Amend Articles to Make Technical Changes CORPORATE GOVERNANCE ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Naito, Haruo DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Ike, Fumihiko DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Miura, Ryota DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Kato, Hiroyuki DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Richard Thornley DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Moriyama, Toru DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Yasuda, Yuko DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Kanai, Takuji DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Takahashi, Kenta DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Okada, Yasushi DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Eisai Co., Ltd. J12852117 JP3160400002 06/18/2025 Elect Director Ueda, Ryoko DIRECTOR ELECTIONS ISSUER 6830.000000 0 FOR 6830.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Approve Discharge of Directors CORPORATE GOVERNANCE ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Reelect P.A. Chambre as Director DIRECTOR ELECTIONS ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Reelect H.L. Mason as Director DIRECTOR ELECTIONS ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Elect A.S. Reicin as Director DIRECTOR ELECTIONS ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Authorize Repurchase of Ordinary Shares or Depositary Receipts CAPITAL STRUCTURE ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Approve 2025 Stock Option and Incentive Plan COMPENSATION ISSUER 409719.000000 0 FOR 409719.000000 FOR Immatics N.V. N44445109 NL0015285941 06/18/2025 Ratify PricewaterhouseCoopers Accountants N.V. as Auditors AUDIT-RELATED ISSUER 409719.000000 0 FOR 409719.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Approve Allocation of Income, with a Final Dividend of JPY 33 CAPITAL STRUCTURE ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Amend Articles to Adopt Board Structure with Audit Committee - Amend Provisions on Number of Directors - Authorize Directors to Execute Day to Day Operations without Full Board Approval CORPORATE GOVERNANCE ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director Teshirogi, Isao DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director Ando, Keiichi DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director Ozaki, Hiroshi DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director Fujiwara, Takaoki DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director John Keller DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director Hirose, Kyoko DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director and Audit Committee Member Kishida, Noriyuki DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director and Audit Committee Member Hanasaki, Koji DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director and Audit Committee Member Okuhara, Shuichi DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director and Audit Committee Member Takatsuki, Fumi DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Director and Audit Committee Member Goto, Yoriko DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Elect Alternate Director and Audit Committee Member Hirose, Kyoko DIRECTOR ELECTIONS ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Approve Compensation Ceiling for Directors Who Are Not Audit Committee Members COMPENSATION ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Approve Compensation Ceiling for Directors Who Are Audit Committee Members COMPENSATION ISSUER 23121.000000 0 FOR 23121.000000 FOR Shionogi & Co., Ltd. J74229105 JP3347200002 06/18/2025 Approve Restricted Stock Plan COMPENSATION ISSUER 23121.000000 0 FOR 23121.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Yasukawa, Kenji DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Okamura, Naoki DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Sugita, Katsuyoshi DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Tanaka, Takashi DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Sakurai, Eriko DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Miyazaki, Masahiro DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Ono, Yoichi DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Andreas Busch DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director Mark Enyedy DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Elect Director and Audit Committee Member Akiyama, Rie DIRECTOR ELECTIONS ISSUER 44419.000000 0 FOR 44419.000000 FOR Astellas Pharma, Inc. J03393105 JP3942400007 06/19/2025 Approve Compensation Ceiling for Directors Who Are Not Audit Committee Members COMPENSATION ISSUER 44419.000000 0 FOR 44419.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Approve Allocation of Income, with a Final Dividend of JPY 40 CAPITAL STRUCTURE ISSUER 11330.000000 0 FOR 11330.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Elect Director Sagara, Gyo DIRECTOR ELECTIONS ISSUER 11330.000000 0 FOR 11330.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Elect Director Takino, Toichi DIRECTOR ELECTIONS ISSUER 11330.000000 0 FOR 11330.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Elect Director Tsujinaka, Toshihiro DIRECTOR ELECTIONS ISSUER 11330.000000 0 FOR 11330.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Elect Director Nomura, Masao DIRECTOR ELECTIONS ISSUER 11330.000000 0 FOR 11330.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Elect Director Okuno, Akiko DIRECTOR ELECTIONS ISSUER 11330.000000 0 FOR 11330.000000 FOR Ono Pharmaceutical Co., Ltd. J61546115 JP3197600004 06/19/2025 Elect Director Nagae, Shusaku DIRECTOR ELECTIONS ISSUER 11330.000000 0 FOR 11330.000000 FOR Alpha-9 Oncology Inc. 06/20/2025 Appointment of Auditor: Appointment of KPMG LLP of Vancouver, British Columba as auditors for the Company for the 2025 fiscal year and authorization of the directors to fix their remuneration. AUDIT-RELATED ISSUER 2871748.000000 0.000000 FOR 2871748.000000 FOR Alpha-9 Oncology Inc. 06/20/2025 Number of Directors: Setting the number of directors of the Company at nine (9). CORPORATE GOVERNANCE ISSUER 2871748.000000 0.000000 FOR 2871748.000000 FOR Alpha-9 Oncology Inc. 06/20/2025 Election of Directors: Election of Shelley Chu, Melissa McCracken, Patrick Heron, Evan Rachlin, Matthew Young, Darcy Mootz, Jean-Jacques Bienaime and Steven Stein as directors of the Company for the 2025 fiscal year. DIRECTOR ELECTIONS ISSUER 2871748.000000 0.000000 FOR 2871748.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Approve Allocation of Income, with a Final Dividend of JPY 30 CAPITAL STRUCTURE ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Manabe, Sunao DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Okuzawa, Hiroyuki DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Matsumoto, Takashi DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Komatsu, Yasuhiro DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Nishii, Takaaki DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Homma, Yo DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Joseph Kenneth Keller DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Ueno, Shizuko DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Watanabe, Akihiro DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Elect Director Kinoshita, Reiko DIRECTOR ELECTIONS ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Appoint Statutory Auditor Yokoyama, Terumichi COMPENSATION CORPORATE GOVERNANCE ISSUER 54075.000000 0 FOR 54075.000000 FOR Daiichi Sankyo Co., Ltd. J11257102 JP3475350009 06/23/2025 Appoint Statutory Auditor Watanabe, Masako COMPENSATION CORPORATE GOVERNANCE ISSUER 54075.000000 0 FOR 54075.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Approve Allocation of Income, with a Final Dividend of JPY 13 CAPITAL STRUCTURE ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Takagi, Toshiaki DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Samejima, Hikaru DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Osada, Toshihiko DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Kunimoto, Norimasa DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Nishi, Hidenori DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Ozawa, Keiya DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director Kogiso, Mari DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director and Audit Committee Member Shibazaki, Takanori DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director and Audit Committee Member Uno, Soichiro DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Director and Audit Committee Member Hayashi, Keiko DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Alternate Director and Audit Committee Member Kosugi, Hiroaki DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Terumo Corp. J83173104 JP3546800008 06/24/2025 Elect Alternate Director and Audit Committee Member Shirato, Asako DIRECTOR ELECTIONS ISSUER 34576.000000 0 FOR 34576.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Paul Efron DIRECTOR ELECTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Paul Herendeen DIRECTOR ELECTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Scott Hirsch DIRECTOR ELECTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Sophia Langlois DIRECTOR ELECTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Andy Pasternak DIRECTOR ELECTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To elect, by separate resolutions, six members to our Board of Directors to serve until the next Annual Meeting of Stockholders: Marc Yoskowitz DIRECTOR ELECTIONS ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To approve, on an advisory basis, the compensation of our named executive officers (say-on-pay). SECTION 14A SAY-ON-PAY VOTES ISSUER 30.000000 0 FOR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To approve, on an advisory basis, the frequency of soliciting an advisory say-on-pay vote (say-on-frequency). SECTION 14A SAY-ON-PAY VOTES ISSUER 30.000000 0 ONE YEAR 30.000000 FOR Endo, Inc. 29290D117 US29290D1173 06/25/2025 To approve the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2025 and to authorize the Board of Directors, acting through the Audit & Finance Committee, to determine the independent registered public accounting firm's remuneration. AUDIT-RELATED ISSUER 30.000000 0 FOR 30.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Approve Allocation of Income, with a Final Dividend of JPY 98 CAPITAL STRUCTURE ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Christophe Weber DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Furuta, Mirano DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Andrew Plump DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Iijima, Masami DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Ian Clark DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Steven Gillis DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Higashi, Emiko DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director John Maraganore DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Michel Orsinger DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Elect Director Tsusaka, Miki DIRECTOR ELECTIONS ISSUER 105073.000000 0 FOR 105073.000000 FOR Takeda Pharmaceutical Co., Ltd. 874060205 US8740602052 06/25/2025 Approve Annual Bonus COMPENSATION ISSUER 105073.000000 0 AGAINST 105073.000000 AGAINST Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Approve Allocation of Income, with a Final Dividend of JPY 98 CAPITAL STRUCTURE ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Christophe Weber DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Furuta, Mirano DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Andrew Plump DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Iijima, Masami DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Ian Clark DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Steven Gillis DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Higashi, Emiko DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director John Maraganore DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Michel Orsinger DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Elect Director Tsusaka, Miki DIRECTOR ELECTIONS ISSUER 9600.000000 0 FOR 9600.000000 FOR Takeda Pharmaceutical Co., Ltd. J8129E108 JP3463000004 06/25/2025 Approve Annual Bonus COMPENSATION ISSUER 9600.000000 0 AGAINST 9600.000000 AGAINST HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Yoshihara, Hiroaki DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Abe, Yasuyuki DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Hasegawa, Takayo DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Nishimura, Mika DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Sato, Mototsugu DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Ikeda, Eiichiro DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR HOYA Corp. J22848105 JP3837800006 06/26/2025 Elect Director Hiroka, Ryo DIRECTOR ELECTIONS ISSUER 9682.000000 0 FOR 9682.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Tanimura, Itaru DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Tomaru, Akihiko DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Tsuchiya, Eiji DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Nakamura, Rie DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Tanaka, Yoshinao DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Yamazaki, Satoshi DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR M3, Inc. J4697J108 JP3435750009 06/26/2025 Elect Director Tsugawa, Yusuke DIRECTOR ELECTIONS ISSUER 7436.000000 0 FOR 7436.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Iwasaki, Masato DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director David Robert Hale DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Jimmy C. Beasley DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Ichikawa, Sachiko DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Kan, Kohei DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Gary John Pruden DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Luann Marie Pendy DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Ishino, Hiroshi DIRECTOR ELECTIONS ISSUER 28940.000000 0 AGAINST 28940.000000 AGAINST Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Takeuchi, Yasuo DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Bob White DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR Olympus Corp. J61240107 JP3201200007 06/26/2025 Elect Director Okubo, Toshihiko DIRECTOR ELECTIONS ISSUER 28940.000000 0 FOR 28940.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Adopt Financial Statements and Statutory Reports CORPORATE GOVERNANCE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Remuneration Report COMPENSATION ISSUER 28059.000000 0 AGAINST 28059.000000 AGAINST QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Dividends CAPITAL STRUCTURE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Discharge of Management Board CORPORATE GOVERNANCE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Discharge of Supervisory Board CORPORATE GOVERNANCE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Metin Colpan to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 AGAINST 28059.000000 AGAINST QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Toralf Haag to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Ross L. Levine to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Eva Pisa to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Stephen H. Rusckowski to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Elizabeth E. Tallett to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Bert van Meurs to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Eva van Pelt to Supervisory Board DIRECTOR ELECTIONS ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Thierry Bernard to Management Board CORPORATE GOVERNANCE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Reelect Roland Sackers to Management Board CORPORATE GOVERNANCE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Remuneration Policy COMPENSATION ISSUER 28059.000000 0 AGAINST 28059.000000 AGAINST QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Grant Supervisory Board Authority to Issue Shares CAPITAL STRUCTURE ISSUER 28059.000000 0 AGAINST 28059.000000 AGAINST QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Authorize Supervisory Board to Exclude Preemptive Rights from Share Issuances CAPITAL STRUCTURE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Authorize Repurchase of Shares CAPITAL STRUCTURE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Discretionary Rights for the Managing Board to Implement Capital Repayment by Means of Synthetic Share Repurchase CAPITAL STRUCTURE ISSUER 28059.000000 0 FOR 28059.000000 FOR QIAGEN NV N72482206 NL0015002CX3 06/26/2025 Approve Cancellation of Shares CAPITAL STRUCTURE ISSUER 28059.000000 0 FOR 28059.000000 FOR